chem,cas,cat,mean,median,perc_75,perc_95,perc_99,sample_size,year,frac_nd
Blood Ethylbenzene (ng/mL),100-41-4,Gender: female,,,,0.109,0.214,1473,2017-2018,0.723307745987439
Blood Ethylbenzene (ng/mL),100-41-4,Gender: male,,,0.032,0.128,0.296,1393,2017-2018,0.723307745987439
Blood Ethylbenzene (ng/mL),100-41-4,Income: Missing,,,0.045,0.145,0.22,1197,2017-2018,0.723307745987439
Blood Ethylbenzene (ng/mL),100-41-4,Income: PIR above 2,,,0.025,0.128,0.399,378,2017-2018,0.723307745987439
Blood Ethylbenzene (ng/mL),100-41-4,Income: PIR below 2,,,,0.086,0.218,1291,2017-2018,0.723307745987439
Blood Ethylbenzene (ng/mL),100-41-4,Race/eth: Hispanic,,,,0.069,0.152,682,2017-2018,0.723307745987439
Blood Ethylbenzene (ng/mL),100-41-4,Race/eth: Non-hispanic black,,,0.046,0.127,0.209,637,2017-2018,0.723307745987439
Blood Ethylbenzene (ng/mL),100-41-4,Race/eth: Non-hispanic white,,,0.025,0.129,0.27,977,2017-2018,0.723307745987439
Blood Ethylbenzene (ng/mL),100-41-4,Race/eth: Other,,,0.031,0.14,0.296,570,2017-2018,0.723307745987439
Blood Styrene (ng/mL),100-42-5,Gender: female,,,0.043,0.11,0.268,669,2009-2010,0.565151515151515
Blood Styrene (ng/mL),100-42-5,Gender: male,,0.031,0.053,0.152,0.234,651,2009-2010,0.565151515151515
Blood Styrene (ng/mL),100-42-5,Income: Missing,,,0.039,0.116,0.206,112,2009-2010,0.565151515151515
Blood Styrene (ng/mL),100-42-5,Income: PIR above 2,,,0.049,0.128,0.258,591,2009-2010,0.565151515151515
Blood Styrene (ng/mL),100-42-5,Income: PIR below 2,,,0.05,0.152,0.294,617,2009-2010,0.565151515151515
Blood Styrene (ng/mL),100-42-5,Race/eth: Hispanic,,,0.039,0.084,0.17,495,2009-2010,0.565151515151515
Blood Styrene (ng/mL),100-42-5,Race/eth: Non-hispanic black,,,0.051,0.168,0.318,204,2009-2010,0.565151515151515
Blood Styrene (ng/mL),100-42-5,Race/eth: Non-hispanic white,,0.03,0.053,0.15,0.268,507,2009-2010,0.565151515151515
Blood Styrene (ng/mL),100-42-5,Race/eth: Other,,,0.037,0.092,0.156,114,2009-2010,0.565151515151515
N-Nitrosopiperidine (NPIP) (ng/L),100-75-4,Gender: female,,,,,36.7,1272,2013-2014,0.945432977461447
N-Nitrosopiperidine (NPIP) (ng/L),100-75-4,Gender: male,,,,,26.7,1257,2013-2014,0.945432977461447
N-Nitrosopiperidine (NPIP) (ng/L),100-75-4,Income: Missing,,,,,16.6,180,2013-2014,0.945432977461447
N-Nitrosopiperidine (NPIP) (ng/L),100-75-4,Income: PIR above 2,,,,6.47,52.4,1229,2013-2014,0.945432977461447
N-Nitrosopiperidine (NPIP) (ng/L),100-75-4,Income: PIR below 2,,,,,26.7,1120,2013-2014,0.945432977461447
N-Nitrosopiperidine (NPIP) (ng/L),100-75-4,Race/eth: Hispanic,,,,8.24,33.2,679,2013-2014,0.945432977461447
N-Nitrosopiperidine (NPIP) (ng/L),100-75-4,Race/eth: Non-hispanic black,,,,7.67,74.4,544,2013-2014,0.945432977461447
N-Nitrosopiperidine (NPIP) (ng/L),100-75-4,Race/eth: Non-hispanic white,,,,,26.7,921,2013-2014,0.945432977461447
N-Nitrosopiperidine (NPIP) (ng/L),100-75-4,Race/eth: Other,,,,5.32,19.1,385,2013-2014,0.945432977461447
"4,4'-Diaminodiphenylmethane (ng/mL)",101-77-9,Gender: female,,0.053,0.174,0.373,0.507,1412,2015-2016,0.440480395619922
"4,4'-Diaminodiphenylmethane (ng/mL)",101-77-9,Gender: male,,0.064,0.166,0.384,0.695,1419,2015-2016,0.440480395619922
"4,4'-Diaminodiphenylmethane (ng/mL)",101-77-9,Income: Missing,,0.075,0.175,0.332,0.627,290,2015-2016,0.440480395619922
"4,4'-Diaminodiphenylmethane (ng/mL)",101-77-9,Income: PIR above 2,,0.059,0.157,0.387,0.791,1348,2015-2016,0.440480395619922
"4,4'-Diaminodiphenylmethane (ng/mL)",101-77-9,Income: PIR below 2,,0.055,0.173,0.384,0.518,1193,2015-2016,0.440480395619922
"4,4'-Diaminodiphenylmethane (ng/mL)",101-77-9,Race/eth: Hispanic,,0.065,0.163,0.404,0.911,923,2015-2016,0.440480395619922
"4,4'-Diaminodiphenylmethane (ng/mL)",101-77-9,Race/eth: Non-hispanic black,,0.07,0.192,0.419,0.698,601,2015-2016,0.440480395619922
"4,4'-Diaminodiphenylmethane (ng/mL)",101-77-9,Race/eth: Non-hispanic white,,0.055,0.174,0.373,0.499,858,2015-2016,0.440480395619922
"4,4'-Diaminodiphenylmethane (ng/mL)",101-77-9,Race/eth: Other,,,0.147,0.388,1.94,449,2015-2016,0.440480395619922
Heptachlor Epoxide (ng/g),1024-57-3,Gender: female,,,,0.1332,0.2395,1007,2003-2004,0.779419256240448
Heptachlor Epoxide (ng/g),1024-57-3,Gender: male,,,,0.1256,0.2062,956,2003-2004,0.779419256240448
Heptachlor Epoxide (ng/g),1024-57-3,Income: Missing,,,0.0441,0.1121,0.135,102,2003-2004,0.779419256240448
Heptachlor Epoxide (ng/g),1024-57-3,Income: PIR above 2,,,,0.1385,0.2138,940,2003-2004,0.779419256240448
Heptachlor Epoxide (ng/g),1024-57-3,Income: PIR below 2,,,,0.1257,0.2395,921,2003-2004,0.779419256240448
Heptachlor Epoxide (ng/g),1024-57-3,Race/eth: Hispanic,,,,0.0996,0.1735,525,2003-2004,0.779419256240448
Heptachlor Epoxide (ng/g),1024-57-3,Race/eth: Non-hispanic black,,,,0.1101,0.2225,479,2003-2004,0.779419256240448
Heptachlor Epoxide (ng/g),1024-57-3,Race/eth: Non-hispanic white,,,0.0392,0.135,0.2395,879,2003-2004,0.779419256240448
Heptachlor Epoxide (ng/g),1024-57-3,Race/eth: Other,,,,0.1281,0.188,80,2003-2004,0.779419256240448
Heptachlor Epoxide Lipid Adj (ng/g),1024-57-3,Gender: female,,,,19.6,35.8,1007,2003-2004,0.779419256240448
Heptachlor Epoxide Lipid Adj (ng/g),1024-57-3,Gender: male,,,,18.6,32.6,956,2003-2004,0.779419256240448
Heptachlor Epoxide Lipid Adj (ng/g),1024-57-3,Income: Missing,,,7.9,14.5,21.1,102,2003-2004,0.779419256240448
Heptachlor Epoxide Lipid Adj (ng/g),1024-57-3,Income: PIR above 2,,,,19.6,27.2,940,2003-2004,0.779419256240448
Heptachlor Epoxide Lipid Adj (ng/g),1024-57-3,Income: PIR below 2,,,,18.9,35.8,921,2003-2004,0.779419256240448
Heptachlor Epoxide Lipid Adj (ng/g),1024-57-3,Race/eth: Hispanic,,,,15.1,23.2,525,2003-2004,0.779419256240448
Heptachlor Epoxide Lipid Adj (ng/g),1024-57-3,Race/eth: Non-hispanic black,,,,18.6,32.8,479,2003-2004,0.779419256240448
Heptachlor Epoxide Lipid Adj (ng/g),1024-57-3,Race/eth: Non-hispanic white,,,7.9,20.4,36.6,879,2003-2004,0.779419256240448
Heptachlor Epoxide Lipid Adj (ng/g),1024-57-3,Race/eth: Other,,,,16.7,26.8,80,2003-2004,0.779419256240448
"N,N-Dimethylformamide metabolite: N-acetyl-S-(N-methylcarbamoyl)-L-cysteine (ng/mL)",68-12-2,Gender: female,104.137002598001,99.3,221,627,1380,1494,2015-2016,0.00539629005059022
"N,N-Dimethylformamide metabolite: N-acetyl-S-(N-methylcarbamoyl)-L-cysteine (ng/mL)",68-12-2,Gender: male,126.543742055891,117,262,798,1480,1471,2015-2016,0.00539629005059022
"N,N-Dimethylformamide metabolite: N-acetyl-S-(N-methylcarbamoyl)-L-cysteine (ng/mL)",68-12-2,Income: Missing,124.233134081031,117,274,922,2180,309,2015-2016,0.00539629005059022
"N,N-Dimethylformamide metabolite: N-acetyl-S-(N-methylcarbamoyl)-L-cysteine (ng/mL)",68-12-2,Income: PIR above 2,115.414551456012,113,245,841,1740,1396,2015-2016,0.00539629005059022
"N,N-Dimethylformamide metabolite: N-acetyl-S-(N-methylcarbamoyl)-L-cysteine (ng/mL)",68-12-2,Income: PIR below 2,112.556409572988,105,238,650,1200,1260,2015-2016,0.00539629005059022
"N,N-Dimethylformamide metabolite: N-acetyl-S-(N-methylcarbamoyl)-L-cysteine (ng/mL)",68-12-2,Race/eth: Hispanic,124.641073044974,93.1,185,489,1100,962,2015-2016,0.00539629005059022
"N,N-Dimethylformamide metabolite: N-acetyl-S-(N-methylcarbamoyl)-L-cysteine (ng/mL)",68-12-2,Race/eth: Non-hispanic black,119.099352719505,107,228,882,1470,643,2015-2016,0.00539629005059022
"N,N-Dimethylformamide metabolite: N-acetyl-S-(N-methylcarbamoyl)-L-cysteine (ng/mL)",68-12-2,Race/eth: Non-hispanic white,97.6350326954931,117,268,822,1520,885,2015-2016,0.00539629005059022
"N,N-Dimethylformamide metabolite: N-acetyl-S-(N-methylcarbamoyl)-L-cysteine (ng/mL)",68-12-2,Race/eth: Other,85.3423877043669,78.7,175,564,1050,475,2015-2016,0.00539629005059022
"2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (pg/mL)",105650-23-5,Gender: female,,0.38,1.7,14.3,58.2,1284,2013-2014,0.429349941611522
"2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (pg/mL)",105650-23-5,Gender: male,,0.53,2.08,17.3,59.1,1285,2013-2014,0.429349941611522
"2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (pg/mL)",105650-23-5,Income: Missing,,,2.04,17.3,119,180,2013-2014,0.429349941611522
"2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (pg/mL)",105650-23-5,Income: PIR above 2,,0.42,1.55,9.19,56.4,1244,2013-2014,0.429349941611522
"2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (pg/mL)",105650-23-5,Income: PIR below 2,,0.52,2.08,19.1,58.2,1145,2013-2014,0.429349941611522
"2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (pg/mL)",105650-23-5,Race/eth: Hispanic,,0.65,2.61,14.6,92.8,683,2013-2014,0.429349941611522
"2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (pg/mL)",105650-23-5,Race/eth: Non-hispanic black,,0.75,2.31,17.4,48,554,2013-2014,0.429349941611522
"2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (pg/mL)",105650-23-5,Race/eth: Non-hispanic white,,0.39,1.61,16.8,53.1,945,2013-2014,0.429349941611522
"2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (pg/mL)",105650-23-5,Race/eth: Other,,,1.5,13.6,47.4,387,2013-2014,0.429349941611522
N-Nitrosoethylmethylamine (NMEA) (ng/L),10595-95-6,Gender: female,,,,,,1247,2013-2014,0.992825827022718
N-Nitrosoethylmethylamine (NMEA) (ng/L),10595-95-6,Gender: male,,,,,,1262,2013-2014,0.992825827022718
N-Nitrosoethylmethylamine (NMEA) (ng/L),10595-95-6,Income: Missing,,,,,5.87,179,2013-2014,0.992825827022718
N-Nitrosoethylmethylamine (NMEA) (ng/L),10595-95-6,Income: PIR above 2,,,,,,1212,2013-2014,0.992825827022718
N-Nitrosoethylmethylamine (NMEA) (ng/L),10595-95-6,Income: PIR below 2,,,,,,1118,2013-2014,0.992825827022718
N-Nitrosoethylmethylamine (NMEA) (ng/L),10595-95-6,Race/eth: Hispanic,,,,,,675,2013-2014,0.992825827022718
N-Nitrosoethylmethylamine (NMEA) (ng/L),10595-95-6,Race/eth: Non-hispanic black,,,,,,539,2013-2014,0.992825827022718
N-Nitrosoethylmethylamine (NMEA) (ng/L),10595-95-6,Race/eth: Non-hispanic white,,,,,,911,2013-2014,0.992825827022718
N-Nitrosoethylmethylamine (NMEA) (ng/L),10595-95-6,Race/eth: Other,,,,,,384,2013-2014,0.992825827022718
"Blood 1,4-Dichlorobenzene (ng/mL)",106-46-7,Gender: female,,,0.057,0.672,5.51,1467,2017-2018,0.608056042031524
"Blood 1,4-Dichlorobenzene (ng/mL)",106-46-7,Gender: male,,,0.071,0.758,4.92,1388,2017-2018,0.608056042031524
"Blood 1,4-Dichlorobenzene (ng/mL)",106-46-7,Income: Missing,,,0.084,0.872,18.4,1191,2017-2018,0.608056042031524
"Blood 1,4-Dichlorobenzene (ng/mL)",106-46-7,Income: PIR above 2,,,0.125,1.06,5.09,376,2017-2018,0.608056042031524
"Blood 1,4-Dichlorobenzene (ng/mL)",106-46-7,Income: PIR below 2,,,0.049,0.451,4.67,1288,2017-2018,0.608056042031524
"Blood 1,4-Dichlorobenzene (ng/mL)",106-46-7,Race/eth: Hispanic,,,0.093,0.997,5.22,679,2017-2018,0.608056042031524
"Blood 1,4-Dichlorobenzene (ng/mL)",106-46-7,Race/eth: Non-hispanic black,,0.054,0.177,2.53,33.8,630,2017-2018,0.608056042031524
"Blood 1,4-Dichlorobenzene (ng/mL)",106-46-7,Race/eth: Non-hispanic white,,,0.048,0.448,4.67,976,2017-2018,0.608056042031524
"Blood 1,4-Dichlorobenzene (ng/mL)",106-46-7,Race/eth: Other,,,0.05,0.517,2.1,570,2017-2018,0.608056042031524
"Blood 1,2-dibromoethane (ng/mL)",106-93-4,Gender: female,,,,,,1473,2017-2018,1
"Blood 1,2-dibromoethane (ng/mL)",106-93-4,Gender: male,,,,,,1393,2017-2018,1
"Blood 1,2-dibromoethane (ng/mL)",106-93-4,Income: Missing,,,,,,1197,2017-2018,1
"Blood 1,2-dibromoethane (ng/mL)",106-93-4,Income: PIR above 2,,,,,,378,2017-2018,1
"Blood 1,2-dibromoethane (ng/mL)",106-93-4,Income: PIR below 2,,,,,,1291,2017-2018,1
"Blood 1,2-dibromoethane (ng/mL)",106-93-4,Race/eth: Hispanic,,,,,,682,2017-2018,1
"Blood 1,2-dibromoethane (ng/mL)",106-93-4,Race/eth: Non-hispanic black,,,,,,637,2017-2018,1
"Blood 1,2-dibromoethane (ng/mL)",106-93-4,Race/eth: Non-hispanic white,,,,,,977,2017-2018,1
"Blood 1,2-dibromoethane (ng/mL)",106-93-4,Race/eth: Other,,,,,,570,2017-2018,1
"1,3-Butadiene metabolite: N-Acetyl-S-(4-hydroxy-2-butenyl)-L-Cysteine (ng/mL)",106-99-0,Gender: female,3.59079039368276,3.26,6.87,33.1,94.1,1516,2015-2016,0.0570480928689884
"1,3-Butadiene metabolite: N-Acetyl-S-(4-hydroxy-2-butenyl)-L-Cysteine (ng/mL)",106-99-0,Gender: male,4.89440926041286,4.83,8.81,43.4,107,1499,2015-2016,0.0570480928689884
"1,3-Butadiene metabolite: N-Acetyl-S-(4-hydroxy-2-butenyl)-L-Cysteine (ng/mL)",106-99-0,Income: Missing,4.395357322368,4.54,8.52,50.3,123,311,2015-2016,0.0570480928689884
"1,3-Butadiene metabolite: N-Acetyl-S-(4-hydroxy-2-butenyl)-L-Cysteine (ng/mL)",106-99-0,Income: PIR above 2,4.83477245492213,4.54,9.99,48.1,125,1433,2015-2016,0.0570480928689884
"1,3-Butadiene metabolite: N-Acetyl-S-(4-hydroxy-2-butenyl)-L-Cysteine (ng/mL)",106-99-0,Income: PIR below 2,3.82095786392004,3.78,6.93,31.2,70.2,1271,2015-2016,0.0570480928689884
"1,3-Butadiene metabolite: N-Acetyl-S-(4-hydroxy-2-butenyl)-L-Cysteine (ng/mL)",106-99-0,Race/eth: Hispanic,4.16660386136617,3.81,6.46,21.9,49.4,970,2015-2016,0.0570480928689884
"1,3-Butadiene metabolite: N-Acetyl-S-(4-hydroxy-2-butenyl)-L-Cysteine (ng/mL)",106-99-0,Race/eth: Non-hispanic black,6.66708800248726,5.94,13.4,52.9,137,656,2015-2016,0.0570480928689884
"1,3-Butadiene metabolite: N-Acetyl-S-(4-hydroxy-2-butenyl)-L-Cysteine (ng/mL)",106-99-0,Race/eth: Non-hispanic white,3.53058475275329,3.89,7.63,45.5,109,912,2015-2016,0.0570480928689884
"1,3-Butadiene metabolite: N-Acetyl-S-(4-hydroxy-2-butenyl)-L-Cysteine (ng/mL)",106-99-0,Race/eth: Other,3.25454955684481,3.51,7.83,28.2,67.7,477,2015-2016,0.0570480928689884
Blood Methyl Isobutyl Ketone (ng/mL),108-10-1,Gender: female,,,,,,1471,2017-2018,0.993011879804333
Blood Methyl Isobutyl Ketone (ng/mL),108-10-1,Gender: male,,,,,,1391,2017-2018,0.993011879804333
Blood Methyl Isobutyl Ketone (ng/mL),108-10-1,Income: Missing,,,,,,1196,2017-2018,0.993011879804333
Blood Methyl Isobutyl Ketone (ng/mL),108-10-1,Income: PIR above 2,,,,,,378,2017-2018,0.993011879804333
Blood Methyl Isobutyl Ketone (ng/mL),108-10-1,Income: PIR below 2,,,,,,1288,2017-2018,0.993011879804333
Blood Methyl Isobutyl Ketone (ng/mL),108-10-1,Race/eth: Hispanic,,,,,,682,2017-2018,0.993011879804333
Blood Methyl Isobutyl Ketone (ng/mL),108-10-1,Race/eth: Non-hispanic black,,,,,,637,2017-2018,0.993011879804333
Blood Methyl Isobutyl Ketone (ng/mL),108-10-1,Race/eth: Non-hispanic white,,,,,,974,2017-2018,0.993011879804333
Blood Methyl Isobutyl Ketone (ng/mL),108-10-1,Race/eth: Other,,,,,,569,2017-2018,0.993011879804333
Melamine (ng/mL),108-78-1,Gender: female,1.435837405469,2.6,4.31,12.02,30.22,256,2003-2004,0.241735537190083
Melamine (ng/mL),108-78-1,Gender: male,1.20353526236216,2.92,4.26,13.32,41.41,228,2003-2004,0.241735537190083
Melamine (ng/mL),108-78-1,Income: Missing,0.967541123373395,1.72,3.98,8.4,16.18,21,2003-2004,0.241735537190083
Melamine (ng/mL),108-78-1,Income: PIR above 2,1.30183216110688,2.78,4.26,12.02,41.41,215,2003-2004,0.241735537190083
Melamine (ng/mL),108-78-1,Income: PIR below 2,1.37728638701628,2.97,4.66,13.32,21.04,248,2003-2004,0.241735537190083
Melamine (ng/mL),108-78-1,Race/eth: Hispanic,1.44525279587597,3.35,5.2,16.18,25.81,131,2003-2004,0.241735537190083
Melamine (ng/mL),108-78-1,Race/eth: Non-hispanic black,0.929065943264757,2.93,4.44,12.02,40.88,129,2003-2004,0.241735537190083
Melamine (ng/mL),108-78-1,Race/eth: Non-hispanic white,0.953180751774717,2.71,4.23,11.48,41.41,206,2003-2004,0.241735537190083
Melamine (ng/mL),108-78-1,Race/eth: Other,2.12595641038286,2.47,3.38,4.64,8.24,18,2003-2004,0.241735537190083
Blood Tetrahydrofuran (ng/mL),109-99-9,Gender: female,,,,,,1460,2017-2018,0.995779106577559
Blood Tetrahydrofuran (ng/mL),109-99-9,Gender: male,,,,,,1383,2017-2018,0.995779106577559
Blood Tetrahydrofuran (ng/mL),109-99-9,Income: Missing,,,,,,1190,2017-2018,0.995779106577559
Blood Tetrahydrofuran (ng/mL),109-99-9,Income: PIR above 2,,,,,,378,2017-2018,0.995779106577559
Blood Tetrahydrofuran (ng/mL),109-99-9,Income: PIR below 2,,,,,,1275,2017-2018,0.995779106577559
Blood Tetrahydrofuran (ng/mL),109-99-9,Race/eth: Hispanic,,,,,,681,2017-2018,0.995779106577559
Blood Tetrahydrofuran (ng/mL),109-99-9,Race/eth: Non-hispanic black,,,,,,635,2017-2018,0.995779106577559
Blood Tetrahydrofuran (ng/mL),109-99-9,Race/eth: Non-hispanic white,,,,,,964,2017-2018,0.995779106577559
Blood Tetrahydrofuran (ng/mL),109-99-9,Race/eth: Other,,,,,,563,2017-2018,0.995779106577559
Blood furan (ng/mL),110-00-9,Gender: female,,,,0.08,0.182,1457,2017-2018,0.843013023583245
Blood furan (ng/mL),110-00-9,Gender: male,,,,0.093,0.16,1384,2017-2018,0.843013023583245
Blood furan (ng/mL),110-00-9,Income: Missing,,,0.025,0.13,0.195,1180,2017-2018,0.843013023583245
Blood furan (ng/mL),110-00-9,Income: PIR above 2,,,,0.079,0.4,377,2017-2018,0.843013023583245
Blood furan (ng/mL),110-00-9,Income: PIR below 2,,,,0.049,0.134,1284,2017-2018,0.843013023583245
Blood furan (ng/mL),110-00-9,Race/eth: Hispanic,,,,0.037,0.073,682,2017-2018,0.843013023583245
Blood furan (ng/mL),110-00-9,Race/eth: Non-hispanic black,,,,0.094,0.188,627,2017-2018,0.843013023583245
Blood furan (ng/mL),110-00-9,Race/eth: Non-hispanic white,,,,0.09,0.188,965,2017-2018,0.843013023583245
Blood furan (ng/mL),110-00-9,Race/eth: Other,,,,0.119,0.148,567,2017-2018,0.843013023583245
Tetrachloroethylene metabolite: N-acetyl-s-(trichlorovinyl)-L-cysteine (ng/mL),127-18-4,Gender: female,,,,,,1516,2015-2016,1
Tetrachloroethylene metabolite: N-acetyl-s-(trichlorovinyl)-L-cysteine (ng/mL),127-18-4,Gender: male,,,,,,1499,2015-2016,1
Tetrachloroethylene metabolite: N-acetyl-s-(trichlorovinyl)-L-cysteine (ng/mL),127-18-4,Income: Missing,,,,,,311,2015-2016,1
Tetrachloroethylene metabolite: N-acetyl-s-(trichlorovinyl)-L-cysteine (ng/mL),127-18-4,Income: PIR above 2,,,,,,1433,2015-2016,1
Tetrachloroethylene metabolite: N-acetyl-s-(trichlorovinyl)-L-cysteine (ng/mL),127-18-4,Income: PIR below 2,,,,,,1271,2015-2016,1
Tetrachloroethylene metabolite: N-acetyl-s-(trichlorovinyl)-L-cysteine (ng/mL),127-18-4,Race/eth: Hispanic,,,,,,970,2015-2016,1
Tetrachloroethylene metabolite: N-acetyl-s-(trichlorovinyl)-L-cysteine (ng/mL),127-18-4,Race/eth: Non-hispanic black,,,,,,656,2015-2016,1
Tetrachloroethylene metabolite: N-acetyl-s-(trichlorovinyl)-L-cysteine (ng/mL),127-18-4,Race/eth: Non-hispanic white,,,,,,912,2015-2016,1
Tetrachloroethylene metabolite: N-acetyl-s-(trichlorovinyl)-L-cysteine (ng/mL),127-18-4,Race/eth: Other,,,,,,477,2015-2016,1
Hexachlorobenzene (ng/g),118-74-1,Gender: female,0.0891967345803772,0.0924,0.123,0.19,0.3681,1004,2003-2004,0.041305456399796
Hexachlorobenzene (ng/g),118-74-1,Gender: male,0.0936523769941603,0.0867,0.1153,0.1788,0.2916,957,2003-2004,0.041305456399796
Hexachlorobenzene (ng/g),118-74-1,Income: Missing,0.0899446967115395,0.0941,0.1112,0.1664,0.2118,103,2003-2004,0.041305456399796
Hexachlorobenzene (ng/g),118-74-1,Income: PIR above 2,0.087735672559553,0.0834,0.1186,0.1985,0.392,933,2003-2004,0.041305456399796
Hexachlorobenzene (ng/g),118-74-1,Income: PIR below 2,0.0936998309893455,0.0923,0.1206,0.1816,0.3067,925,2003-2004,0.041305456399796
Hexachlorobenzene (ng/g),118-74-1,Race/eth: Hispanic,0.0795528738361901,0.0883,0.1219,0.2497,1.1847,525,2003-2004,0.041305456399796
Hexachlorobenzene (ng/g),118-74-1,Race/eth: Non-hispanic black,0.0952978008650171,0.0778,0.1035,0.1664,0.2615,477,2003-2004,0.041305456399796
Hexachlorobenzene (ng/g),118-74-1,Race/eth: Non-hispanic white,0.0927121435657591,0.0921,0.121,0.1816,0.289,879,2003-2004,0.041305456399796
Hexachlorobenzene (ng/g),118-74-1,Race/eth: Other,0.0933317993057708,0.0976,0.1121,0.1487,0.7317,80,2003-2004,0.041305456399796
Hexachlorobenzene Lipid Adj (ng/g),118-74-1,Gender: female,14.4075645257255,15.7,20,29.8,65.6,1004,2003-2004,0.041305456399796
Hexachlorobenzene Lipid Adj (ng/g),118-74-1,Gender: male,15.6246656788009,14.2,18.1,26.9,47.4,957,2003-2004,0.041305456399796
Hexachlorobenzene Lipid Adj (ng/g),118-74-1,Income: Missing,15.1422622343703,15,19.7,26.1,29.8,103,2003-2004,0.041305456399796
Hexachlorobenzene Lipid Adj (ng/g),118-74-1,Income: PIR above 2,14.5629159780088,14.6,19.2,31.3,67.1,933,2003-2004,0.041305456399796
Hexachlorobenzene Lipid Adj (ng/g),118-74-1,Income: PIR below 2,15.2666303134108,15.1,18.9,28.5,51.2,925,2003-2004,0.041305456399796
Hexachlorobenzene Lipid Adj (ng/g),118-74-1,Race/eth: Hispanic,14.241074459036,14.6,19.7,38.1,174,525,2003-2004,0.041305456399796
Hexachlorobenzene Lipid Adj (ng/g),118-74-1,Race/eth: Non-hispanic black,15.6210164565688,14.1,18.3,26.6,40.1,477,2003-2004,0.041305456399796
Hexachlorobenzene Lipid Adj (ng/g),118-74-1,Race/eth: Non-hispanic white,15.0061044241344,15,19.2,28.4,47.4,879,2003-2004,0.041305456399796
Hexachlorobenzene Lipid Adj (ng/g),118-74-1,Race/eth: Other,15.606339003575,16,17.9,26.1,90.8,80,2003-2004,0.041305456399796
"Blood 1,4-Dioxane (ng/mL)",123-91-1,Gender: female,,,,,,1491,2015-2016,1
"Blood 1,4-Dioxane (ng/mL)",123-91-1,Gender: male,,,,,,1459,2015-2016,1
"Blood 1,4-Dioxane (ng/mL)",123-91-1,Income: Missing,,,,,,292,2015-2016,1
"Blood 1,4-Dioxane (ng/mL)",123-91-1,Income: PIR above 2,,,,,,1343,2015-2016,1
"Blood 1,4-Dioxane (ng/mL)",123-91-1,Income: PIR below 2,,,,,,1315,2015-2016,1
"Blood 1,4-Dioxane (ng/mL)",123-91-1,Race/eth: Hispanic,,,,,,887,2015-2016,1
"Blood 1,4-Dioxane (ng/mL)",123-91-1,Race/eth: Non-hispanic black,,,,,,626,2015-2016,1
"Blood 1,4-Dioxane (ng/mL)",123-91-1,Race/eth: Non-hispanic white,,,,,,974,2015-2016,1
"Blood 1,4-Dioxane (ng/mL)",123-91-1,Race/eth: Other,,,,,,463,2015-2016,1
Urinary Monomethylarsonic acid (ug/L),124-58-3,Gender: female,,,0.59,1.46,2.21,1432,2017-2018,0.551504424778761
Urinary Monomethylarsonic acid (ug/L),124-58-3,Gender: male,,,0.73,1.48,2.32,1393,2017-2018,0.551504424778761
Urinary Monomethylarsonic acid (ug/L),124-58-3,Income: Missing,,,0.83,1.71,3.17,351,2017-2018,0.551504424778761
Urinary Monomethylarsonic acid (ug/L),124-58-3,Income: PIR above 2,,,0.63,1.43,1.97,1194,2017-2018,0.551504424778761
Urinary Monomethylarsonic acid (ug/L),124-58-3,Income: PIR below 2,,,0.71,1.42,2.32,1280,2017-2018,0.551504424778761
Urinary Monomethylarsonic acid (ug/L),124-58-3,Race/eth: Hispanic,,0.23,0.8,1.65,3.05,676,2017-2018,0.551504424778761
Urinary Monomethylarsonic acid (ug/L),124-58-3,Race/eth: Non-hispanic black,,,0.69,1.46,2.86,644,2017-2018,0.551504424778761
Urinary Monomethylarsonic acid (ug/L),124-58-3,Race/eth: Non-hispanic white,,,0.58,1.37,1.87,926,2017-2018,0.551504424778761
Urinary Monomethylarsonic acid (ug/L),124-58-3,Race/eth: Other,,0.31,0.84,1.63,2.8,579,2017-2018,0.551504424778761
Blood Tetrachloroethene (ng/mL),127-18-4,Gender: female,,,,0.053,0.528,1400,2017-2018,0.938325991189427
Blood Tetrachloroethene (ng/mL),127-18-4,Gender: male,,,,0.085,1.11,1324,2017-2018,0.938325991189427
Blood Tetrachloroethene (ng/mL),127-18-4,Income: Missing,,,,,0.942,1134,2017-2018,0.938325991189427
Blood Tetrachloroethene (ng/mL),127-18-4,Income: PIR above 2,,,,,0.376,360,2017-2018,0.938325991189427
Blood Tetrachloroethene (ng/mL),127-18-4,Income: PIR below 2,,,,0.087,1.28,1230,2017-2018,0.938325991189427
Blood Tetrachloroethene (ng/mL),127-18-4,Race/eth: Hispanic,,,,0.056,0.376,636,2017-2018,0.938325991189427
Blood Tetrachloroethene (ng/mL),127-18-4,Race/eth: Non-hispanic black,,,,0.074,0.322,607,2017-2018,0.938325991189427
Blood Tetrachloroethene (ng/mL),127-18-4,Race/eth: Non-hispanic white,,,,0.077,1.28,952,2017-2018,0.938325991189427
Blood Tetrachloroethene (ng/mL),127-18-4,Race/eth: Other,,,,,0.195,529,2017-2018,0.938325991189427
"1-Aminonaphthalene, urine (pg/mL)",134-32-7,Gender: female,2.68322708370315,1.88,4.61,77.9,181,1238,2013-2014,0.283292978208232
"1-Aminonaphthalene, urine (pg/mL)",134-32-7,Gender: male,3.14925285417656,2.15,6.16,90.3,194,1240,2013-2014,0.283292978208232
"1-Aminonaphthalene, urine (pg/mL)",134-32-7,Income: Missing,2.11016782278789,1.39,3.43,50.6,281,177,2013-2014,0.283292978208232
"1-Aminonaphthalene, urine (pg/mL)",134-32-7,Income: PIR above 2,4.1988605700546,2.63,10.8,122,210,1196,2013-2014,0.283292978208232
"1-Aminonaphthalene, urine (pg/mL)",134-32-7,Income: PIR below 2,2.36876509075714,1.71,3.96,62.7,134,1105,2013-2014,0.283292978208232
"1-Aminonaphthalene, urine (pg/mL)",134-32-7,Race/eth: Hispanic,5.5999182996992,1.88,3.55,35.8,118,665,2013-2014,0.283292978208232
"1-Aminonaphthalene, urine (pg/mL)",134-32-7,Race/eth: Non-hispanic black,2.30541387359889,3.33,22.9,131,208,532,2013-2014,0.283292978208232
"1-Aminonaphthalene, urine (pg/mL)",134-32-7,Race/eth: Non-hispanic white,2.24745315444354,1.88,5.43,89,194,904,2013-2014,0.283292978208232
"1-Aminonaphthalene, urine (pg/mL)",134-32-7,Race/eth: Other,2.84129363896327,1.68,3.52,47.5,113,377,2013-2014,0.283292978208232
Acrylamide metabolite: N-acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine (ng/mL),79-06-1,Gender: female,,,12.1,29.8,59,1516,2015-2016,0.602985074626866
Acrylamide metabolite: N-acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine (ng/mL),79-06-1,Gender: male,,,15.2,35.8,67,1499,2015-2016,0.602985074626866
Acrylamide metabolite: N-acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine (ng/mL),79-06-1,Income: Missing,,,12.6,34,67,311,2015-2016,0.602985074626866
Acrylamide metabolite: N-acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine (ng/mL),79-06-1,Income: PIR above 2,,,14.4,36.8,74.4,1433,2015-2016,0.602985074626866
Acrylamide metabolite: N-acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine (ng/mL),79-06-1,Income: PIR below 2,,,13.3,29.1,57.4,1271,2015-2016,0.602985074626866
Acrylamide metabolite: N-acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine (ng/mL),79-06-1,Race/eth: Hispanic,,,12.6,29.4,57.9,970,2015-2016,0.602985074626866
Acrylamide metabolite: N-acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine (ng/mL),79-06-1,Race/eth: Non-hispanic black,,10.1,17,46.5,75.8,656,2015-2016,0.602985074626866
Acrylamide metabolite: N-acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine (ng/mL),79-06-1,Race/eth: Non-hispanic white,,,13.6,31,59,912,2015-2016,0.602985074626866
Acrylamide metabolite: N-acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine (ng/mL),79-06-1,Race/eth: Other,,,12.1,30.6,79.2,477,2015-2016,0.602985074626866
"1,3-Butadiene metabolite: N-acetyl-S-(3,4-dihydroxybutyl)-L-cysteine (ng/mL)",106-99-0,Gender: female,283.511384969976,300,506,983,1320,1356,2015-2016,0
"1,3-Butadiene metabolite: N-acetyl-S-(3,4-dihydroxybutyl)-L-cysteine (ng/mL)",106-99-0,Gender: male,349.085482127904,379,573,968,1400,1335,2015-2016,0
"1,3-Butadiene metabolite: N-acetyl-S-(3,4-dihydroxybutyl)-L-cysteine (ng/mL)",106-99-0,Income: Missing,361.871322855591,365,581,1180,1410,280,2015-2016,0
"1,3-Butadiene metabolite: N-acetyl-S-(3,4-dihydroxybutyl)-L-cysteine (ng/mL)",106-99-0,Income: PIR above 2,318.394604747582,352,549,1020,1720,1290,2015-2016,0
"1,3-Butadiene metabolite: N-acetyl-S-(3,4-dihydroxybutyl)-L-cysteine (ng/mL)",106-99-0,Income: PIR below 2,304.394645303317,332,536,917,1260,1121,2015-2016,0
"1,3-Butadiene metabolite: N-acetyl-S-(3,4-dihydroxybutyl)-L-cysteine (ng/mL)",106-99-0,Race/eth: Hispanic,312.950592438827,336,508,877,1430,854,2015-2016,0
"1,3-Butadiene metabolite: N-acetyl-S-(3,4-dihydroxybutyl)-L-cysteine (ng/mL)",106-99-0,Race/eth: Non-hispanic black,383.748387251984,411,618,1020,1600,611,2015-2016,0
"1,3-Butadiene metabolite: N-acetyl-S-(3,4-dihydroxybutyl)-L-cysteine (ng/mL)",106-99-0,Race/eth: Non-hispanic white,303.88610393711,336,556,1000,1330,790,2015-2016,0
"1,3-Butadiene metabolite: N-acetyl-S-(3,4-dihydroxybutyl)-L-cysteine (ng/mL)",106-99-0,Race/eth: Other,262.498771003511,269,458,883,1320,436,2015-2016,0
Acrylonitrile metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),107-13-1,Gender: female,,0.803,1.63,5.53,14.3,1516,2015-2016,0.487230514096186
Acrylonitrile metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),107-13-1,Gender: male,,,1.59,5.06,12,1499,2015-2016,0.487230514096186
Acrylonitrile metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),107-13-1,Income: Missing,,0.817,2.07,8.72,23,311,2015-2016,0.487230514096186
Acrylonitrile metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),107-13-1,Income: PIR above 2,,0.911,1.97,7.47,21.4,1433,2015-2016,0.487230514096186
Acrylonitrile metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),107-13-1,Income: PIR below 2,,,1.41,4.2,8.72,1271,2015-2016,0.487230514096186
Acrylonitrile metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),107-13-1,Race/eth: Hispanic,,,1.71,4.46,14.4,970,2015-2016,0.487230514096186
Acrylonitrile metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),107-13-1,Race/eth: Non-hispanic black,,1.24,2.79,8.38,25,656,2015-2016,0.487230514096186
Acrylonitrile metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),107-13-1,Race/eth: Non-hispanic white,,,1.48,4.31,11,912,2015-2016,0.487230514096186
Acrylonitrile metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),107-13-1,Race/eth: Other,,,1.38,5.8,12.8,477,2015-2016,0.487230514096186
Vinyl Chloride metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-01-4,Gender: female,,0.803,1.63,5.53,14.3,1516,2015-2016,0.487230514096186
Vinyl Chloride metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-01-4,Gender: male,,,1.59,5.06,12,1499,2015-2016,0.487230514096186
Vinyl Chloride metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-01-4,Income: Missing,,0.817,2.07,8.72,23,311,2015-2016,0.487230514096186
Vinyl Chloride metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-01-4,Income: PIR above 2,,0.911,1.97,7.47,21.4,1433,2015-2016,0.487230514096186
Vinyl Chloride metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-01-4,Income: PIR below 2,,,1.41,4.2,8.72,1271,2015-2016,0.487230514096186
Vinyl Chloride metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-01-4,Race/eth: Hispanic,,,1.71,4.46,14.4,970,2015-2016,0.487230514096186
Vinyl Chloride metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-01-4,Race/eth: Non-hispanic black,,1.24,2.79,8.38,25,656,2015-2016,0.487230514096186
Vinyl Chloride metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-01-4,Race/eth: Non-hispanic white,,,1.48,4.31,11,912,2015-2016,0.487230514096186
Vinyl Chloride metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-01-4,Race/eth: Other,,,1.38,5.8,12.8,477,2015-2016,0.487230514096186
Ethylene Oxide metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-21-8,Gender: female,,0.803,1.63,5.53,14.3,1516,2015-2016,0.487230514096186
Ethylene Oxide metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-21-8,Gender: male,,,1.59,5.06,12,1499,2015-2016,0.487230514096186
Ethylene Oxide metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-21-8,Income: Missing,,0.817,2.07,8.72,23,311,2015-2016,0.487230514096186
Ethylene Oxide metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-21-8,Income: PIR above 2,,0.911,1.97,7.47,21.4,1433,2015-2016,0.487230514096186
Ethylene Oxide metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-21-8,Income: PIR below 2,,,1.41,4.2,8.72,1271,2015-2016,0.487230514096186
Ethylene Oxide metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-21-8,Race/eth: Hispanic,,,1.71,4.46,14.4,970,2015-2016,0.487230514096186
Ethylene Oxide metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-21-8,Race/eth: Non-hispanic black,,1.24,2.79,8.38,25,656,2015-2016,0.487230514096186
Ethylene Oxide metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-21-8,Race/eth: Non-hispanic white,,,1.48,4.31,11,912,2015-2016,0.487230514096186
Ethylene Oxide metabolite: N-acetyl-S-(2-Hydroxyethyl)-L-cysteine (ng/mL),75-21-8,Race/eth: Other,,,1.38,5.8,12.8,477,2015-2016,0.487230514096186
"N'-Nitrosonornicotine, urine (ng/mL)",16543-55-8,Gender: female,,,,0.0155,0.0392,4000,2013-2014,0.84551201011378
"N'-Nitrosonornicotine, urine (ng/mL)",16543-55-8,Gender: male,,,,0.0269,0.0736,3910,2013-2014,0.84551201011378
"N'-Nitrosonornicotine, urine (ng/mL)",16543-55-8,Income: Missing,,,,0.0233,0.0402,603,2013-2014,0.84551201011378
"N'-Nitrosonornicotine, urine (ng/mL)",16543-55-8,Income: PIR above 2,,,,0.0155,0.0401,3481,2013-2014,0.84551201011378
"N'-Nitrosonornicotine, urine (ng/mL)",16543-55-8,Income: PIR below 2,,,,0.0294,0.0745,3826,2013-2014,0.84551201011378
"N'-Nitrosonornicotine, urine (ng/mL)",16543-55-8,Race/eth: Hispanic,,,,0.0062,0.0243,2045,2013-2014,0.84551201011378
"N'-Nitrosonornicotine, urine (ng/mL)",16543-55-8,Race/eth: Non-hispanic black,,,,0.0234,0.0593,1749,2013-2014,0.84551201011378
"N'-Nitrosonornicotine, urine (ng/mL)",16543-55-8,Race/eth: Non-hispanic white,,,,0.0239,0.065,2936,2013-2014,0.84551201011378
"N'-Nitrosonornicotine, urine (ng/mL)",16543-55-8,Race/eth: Other,,,,0.0183,0.0568,1180,2013-2014,0.84551201011378
Branched iso of PFOS (ng/mL),1763-23-1,Gender: female,0.942447668438673,0.9,1.8,3.8,7.1,977,2017-2018,0.00829445308449974
Branched iso of PFOS (ng/mL),1763-23-1,Gender: male,1.60486136763713,1.7,2.9,5.3,7.6,952,2017-2018,0.00829445308449974
Branched iso of PFOS (ng/mL),1763-23-1,Income: Missing,1.01226051843755,1,1.9,4.1,7.1,841,2017-2018,0.00829445308449974
Branched iso of PFOS (ng/mL),1763-23-1,Income: PIR above 2,1.10065435691622,1.3,2.1,3.9,7,251,2017-2018,0.00829445308449974
Branched iso of PFOS (ng/mL),1763-23-1,Income: PIR below 2,1.37753890543331,1.4,2.5,4.6,7.5,837,2017-2018,0.00829445308449974
Branched iso of PFOS (ng/mL),1763-23-1,Race/eth: Hispanic,1.03789048043823,0.9,1.6,3.2,6,473,2017-2018,0.00829445308449974
Branched iso of PFOS (ng/mL),1763-23-1,Race/eth: Non-hispanic black,1.045359306332,1,2.1,5.6,7.9,430,2017-2018,0.00829445308449974
Branched iso of PFOS (ng/mL),1763-23-1,Race/eth: Non-hispanic white,1.40004013307109,1.5,2.6,4.6,7.4,667,2017-2018,0.00829445308449974
Branched iso of PFOS (ng/mL),1763-23-1,Race/eth: Other,0.892273785757988,1.1,1.8,4,6.6,359,2017-2018,0.00829445308449974
Linear perfluorooctane sulfonate (ng/mL),1763-23-1,Gender: female,2.39608559930866,2.3,3.9,9.3,17.6,977,2017-2018,0.0031104199066874
Linear perfluorooctane sulfonate (ng/mL),1763-23-1,Gender: male,3.66697836011306,3.7,5.9,11.3,20.5,952,2017-2018,0.0031104199066874
Linear perfluorooctane sulfonate (ng/mL),1763-23-1,Income: Missing,2.63101613175721,2.5,4.4,10.4,20.5,841,2017-2018,0.0031104199066874
Linear perfluorooctane sulfonate (ng/mL),1763-23-1,Income: PIR above 2,2.82411365979733,3.3,5.1,11.1,27.9,251,2017-2018,0.0031104199066874
Linear perfluorooctane sulfonate (ng/mL),1763-23-1,Income: PIR below 2,3.15688259986575,3.2,5.5,10.1,17.6,837,2017-2018,0.0031104199066874
Linear perfluorooctane sulfonate (ng/mL),1763-23-1,Race/eth: Hispanic,3.09258257348746,2.2,3.8,7.5,14.6,473,2017-2018,0.0031104199066874
Linear perfluorooctane sulfonate (ng/mL),1763-23-1,Race/eth: Non-hispanic black,2.78204445422486,3,5.4,16.6,52.6,430,2017-2018,0.0031104199066874
Linear perfluorooctane sulfonate (ng/mL),1763-23-1,Race/eth: Non-hispanic white,3.17530931868916,3.3,5.5,9.6,15.5,667,2017-2018,0.0031104199066874
Linear perfluorooctane sulfonate (ng/mL),1763-23-1,Race/eth: Other,2.22985067452809,2.9,5,16.2,29.1,359,2017-2018,0.0031104199066874
Perfluorooctane sulfonic acid (ng/mL),1763-23-1,Gender: female,3.41335810824338,3.3,5.7,13.1,24,977,2017-2018,0.00414722654224987
Perfluorooctane sulfonic acid (ng/mL),1763-23-1,Gender: male,5.3576071628795,5.5,8.8,15.8,26.2,952,2017-2018,0.00414722654224987
Perfluorooctane sulfonic acid (ng/mL),1763-23-1,Income: Missing,3.71794375185587,3.5,6.4,14,26.2,841,2017-2018,0.00414722654224987
Perfluorooctane sulfonic acid (ng/mL),1763-23-1,Income: PIR above 2,4.01927455669148,4.9,7.3,14.6,32.2,251,2017-2018,0.00414722654224987
Perfluorooctane sulfonic acid (ng/mL),1763-23-1,Income: PIR below 2,4.6154083059796,4.8,8,15.1,24.6,837,2017-2018,0.00414722654224987
Perfluorooctane sulfonic acid (ng/mL),1763-23-1,Race/eth: Hispanic,4.22289785271736,3.1,5.4,10,19.5,473,2017-2018,0.00414722654224987
Perfluorooctane sulfonic acid (ng/mL),1763-23-1,Race/eth: Non-hispanic black,3.93601434787426,4,7.8,21.9,66.8,430,2017-2018,0.00414722654224987
Perfluorooctane sulfonic acid (ng/mL),1763-23-1,Race/eth: Non-hispanic white,4.65334406166166,4.9,8.1,13.9,21.5,667,2017-2018,0.00414722654224987
Perfluorooctane sulfonic acid (ng/mL),1763-23-1,Race/eth: Other,3.17742222484977,4.1,6.9,19.9,33.9,359,2017-2018,0.00414722654224987
Urinary Branched iso of PFOS (ng/mL),1763-23-1,Gender: female,,,,,,1209,2013-2014,1
Urinary Branched iso of PFOS (ng/mL),1763-23-1,Gender: male,,,,,,1119,2013-2014,1
Urinary Branched iso of PFOS (ng/mL),1763-23-1,Income: Missing,,,,,,177,2013-2014,1
Urinary Branched iso of PFOS (ng/mL),1763-23-1,Income: PIR above 2,,,,,,1142,2013-2014,1
Urinary Branched iso of PFOS (ng/mL),1763-23-1,Income: PIR below 2,,,,,,1009,2013-2014,1
Urinary Branched iso of PFOS (ng/mL),1763-23-1,Race/eth: Hispanic,,,,,,611,2013-2014,1
Urinary Branched iso of PFOS (ng/mL),1763-23-1,Race/eth: Non-hispanic black,,,,,,476,2013-2014,1
Urinary Branched iso of PFOS (ng/mL),1763-23-1,Race/eth: Non-hispanic white,,,,,,908,2013-2014,1
Urinary Branched iso of PFOS (ng/mL),1763-23-1,Race/eth: Other,,,,,,333,2013-2014,1
Mirex (ng/g),2385-85-5,Gender: female,,,,0.0767,0.2783,1002,2003-2004,0.902101486417222
Mirex (ng/g),2385-85-5,Gender: male,,,,0.1068,0.2252,949,2003-2004,0.902101486417222
Mirex (ng/g),2385-85-5,Income: Missing,,,,,0.7578,103,2003-2004,0.902101486417222
Mirex (ng/g),2385-85-5,Income: PIR above 2,,,,0.0767,0.2608,931,2003-2004,0.902101486417222
Mirex (ng/g),2385-85-5,Income: PIR below 2,,,,0.1058,0.2562,917,2003-2004,0.902101486417222
Mirex (ng/g),2385-85-5,Race/eth: Hispanic,,,,0.0822,0.1613,524,2003-2004,0.902101486417222
Mirex (ng/g),2385-85-5,Race/eth: Non-hispanic black,,,,0.2562,0.6644,473,2003-2004,0.902101486417222
Mirex (ng/g),2385-85-5,Race/eth: Non-hispanic white,,,,0.0787,0.2153,875,2003-2004,0.902101486417222
Mirex (ng/g),2385-85-5,Race/eth: Other,,,,0.0919,0.1021,79,2003-2004,0.902101486417222
Mirex Lipid Adj (ng/g),2385-85-5,Gender: female,,,,11.6,45.5,1002,2003-2004,0.902101486417222
Mirex Lipid Adj (ng/g),2385-85-5,Gender: male,,,,15.5,40.3,949,2003-2004,0.902101486417222
Mirex Lipid Adj (ng/g),2385-85-5,Income: Missing,,,,,119,103,2003-2004,0.902101486417222
Mirex Lipid Adj (ng/g),2385-85-5,Income: PIR above 2,,,,11.6,33.4,931,2003-2004,0.902101486417222
Mirex Lipid Adj (ng/g),2385-85-5,Income: PIR below 2,,,,15.7,43.2,917,2003-2004,0.902101486417222
Mirex Lipid Adj (ng/g),2385-85-5,Race/eth: Hispanic,,,,12.2,31.3,524,2003-2004,0.902101486417222
Mirex Lipid Adj (ng/g),2385-85-5,Race/eth: Non-hispanic black,,,,40.3,120,473,2003-2004,0.902101486417222
Mirex Lipid Adj (ng/g),2385-85-5,Race/eth: Non-hispanic white,,,,11.6,40.3,875,2003-2004,0.902101486417222
Mirex Lipid Adj (ng/g),2385-85-5,Race/eth: Other,,,,11.6,17.4,79,2003-2004,0.902101486417222
"2-Amino-9H-pyrido[2,3-b]indole (pg/mL)",26148-68-5,Gender: female,,,1.73,54.5,116,1283,2013-2014,0.501947040498442
"2-Amino-9H-pyrido[2,3-b]indole (pg/mL)",26148-68-5,Gender: male,,0.74,2.91,61.4,128,1285,2013-2014,0.501947040498442
"2-Amino-9H-pyrido[2,3-b]indole (pg/mL)",26148-68-5,Income: Missing,,,1.61,47.5,90.7,180,2013-2014,0.501947040498442
"2-Amino-9H-pyrido[2,3-b]indole (pg/mL)",26148-68-5,Income: PIR above 2,,0.75,5.01,79.9,184,1243,2013-2014,0.501947040498442
"2-Amino-9H-pyrido[2,3-b]indole (pg/mL)",26148-68-5,Income: PIR below 2,,,1.63,41.8,97.2,1145,2013-2014,0.501947040498442
"2-Amino-9H-pyrido[2,3-b]indole (pg/mL)",26148-68-5,Race/eth: Hispanic,,0.63,1.63,23.9,107,683,2013-2014,0.501947040498442
"2-Amino-9H-pyrido[2,3-b]indole (pg/mL)",26148-68-5,Race/eth: Non-hispanic black,,0.76,6.63,79.8,147,554,2013-2014,0.501947040498442
"2-Amino-9H-pyrido[2,3-b]indole (pg/mL)",26148-68-5,Race/eth: Non-hispanic white,,0.62,2.69,60.5,117,943,2013-2014,0.501947040498442
"2-Amino-9H-pyrido[2,3-b]indole (pg/mL)",26148-68-5,Race/eth: Other,,,1.32,26.2,52.1,388,2013-2014,0.501947040498442
Di-isononyl phthalate metabolite: Mono-isononyl phthalate (ng/mL),28553-12-0,Gender: female,,,,1.7,9.3,1399,2017-2018,0.865677045619117
Di-isononyl phthalate metabolite: Mono-isononyl phthalate (ng/mL),28553-12-0,Gender: male,,,,1.9,5.9,1363,2017-2018,0.865677045619117
Di-isononyl phthalate metabolite: Mono-isononyl phthalate (ng/mL),28553-12-0,Income: Missing,,,,1.8,8.4,1264,2017-2018,0.865677045619117
Di-isononyl phthalate metabolite: Mono-isononyl phthalate (ng/mL),28553-12-0,Income: PIR above 2,,,,1.4,15.3,337,2017-2018,0.865677045619117
Di-isononyl phthalate metabolite: Mono-isononyl phthalate (ng/mL),28553-12-0,Income: PIR below 2,,,,1.8,5.9,1161,2017-2018,0.865677045619117
Di-isononyl phthalate metabolite: Mono-isononyl phthalate (ng/mL),28553-12-0,Race/eth: Hispanic,,,,2.4,6.2,663,2017-2018,0.865677045619117
Di-isononyl phthalate metabolite: Mono-isononyl phthalate (ng/mL),28553-12-0,Race/eth: Non-hispanic black,,,,1.9,13.9,645,2017-2018,0.865677045619117
Di-isononyl phthalate metabolite: Mono-isononyl phthalate (ng/mL),28553-12-0,Race/eth: Non-hispanic white,,,,1.7,5.9,906,2017-2018,0.865677045619117
Di-isononyl phthalate metabolite: Mono-isononyl phthalate (ng/mL),28553-12-0,Race/eth: Other,,,,1.4,6.6,548,2017-2018,0.865677045619117
Beta-hexachlorocyclohexane (ng/g),319-85-7,Gender: female,,,0.1176,0.4422,2.1211,1007,2003-2004,0.594180704441041
Beta-hexachlorocyclohexane (ng/g),319-85-7,Gender: male,,,0.0687,0.2221,0.685,952,2003-2004,0.594180704441041
Beta-hexachlorocyclohexane (ng/g),319-85-7,Income: Missing,,,0.103,0.4299,2.1208,103,2003-2004,0.594180704441041
Beta-hexachlorocyclohexane (ng/g),319-85-7,Income: PIR above 2,,,0.1021,0.5904,2.2166,938,2003-2004,0.594180704441041
Beta-hexachlorocyclohexane (ng/g),319-85-7,Income: PIR below 2,,,0.0891,0.294,0.9048,918,2003-2004,0.594180704441041
Beta-hexachlorocyclohexane (ng/g),319-85-7,Race/eth: Hispanic,,0.0455,0.1376,0.6922,2.2166,525,2003-2004,0.594180704441041
Beta-hexachlorocyclohexane (ng/g),319-85-7,Race/eth: Non-hispanic black,,,0.0629,0.2881,0.6762,476,2003-2004,0.594180704441041
Beta-hexachlorocyclohexane (ng/g),319-85-7,Race/eth: Non-hispanic white,,,0.0817,0.2869,0.8302,878,2003-2004,0.594180704441041
Beta-hexachlorocyclohexane (ng/g),319-85-7,Race/eth: Other,,0.0829,0.2611,2.2087,22.9709,80,2003-2004,0.594180704441041
Beta-hexachlorocyclohexane Lipid Adj (ng/g),319-85-7,Gender: female,,,18.6,70.3,348,1007,2003-2004,0.594180704441041
Beta-hexachlorocyclohexane Lipid Adj (ng/g),319-85-7,Gender: male,,,10.4,35.3,144,952,2003-2004,0.594180704441041
Beta-hexachlorocyclohexane Lipid Adj (ng/g),319-85-7,Income: Missing,,,17.3,70.3,410,103,2003-2004,0.594180704441041
Beta-hexachlorocyclohexane Lipid Adj (ng/g),319-85-7,Income: PIR above 2,,,16.5,87.6,326,938,2003-2004,0.594180704441041
Beta-hexachlorocyclohexane Lipid Adj (ng/g),319-85-7,Income: PIR below 2,,,13,44.3,144,918,2003-2004,0.594180704441041
Beta-hexachlorocyclohexane Lipid Adj (ng/g),319-85-7,Race/eth: Hispanic,,8.5,23.1,109,348,525,2003-2004,0.594180704441041
Beta-hexachlorocyclohexane Lipid Adj (ng/g),319-85-7,Race/eth: Non-hispanic black,,,9.7,48.8,104,476,2003-2004,0.594180704441041
Beta-hexachlorocyclohexane Lipid Adj (ng/g),319-85-7,Race/eth: Non-hispanic white,,,12.7,40.8,113,878,2003-2004,0.594180704441041
Beta-hexachlorocyclohexane Lipid Adj (ng/g),319-85-7,Race/eth: Other,,9.9,38,671,2850,80,2003-2004,0.594180704441041
Branch perfluorooctanoic acid isomers (ng/mL),335-67-1,Gender: female,,,,0.1,0.2,977,2017-2018,0.900466562986003
Branch perfluorooctanoic acid isomers (ng/mL),335-67-1,Gender: male,,,,0.2,0.3,952,2017-2018,0.900466562986003
Branch perfluorooctanoic acid isomers (ng/mL),335-67-1,Income: Missing,,,,0.1,0.2,841,2017-2018,0.900466562986003
Branch perfluorooctanoic acid isomers (ng/mL),335-67-1,Income: PIR above 2,,,,0.2,0.2,251,2017-2018,0.900466562986003
Branch perfluorooctanoic acid isomers (ng/mL),335-67-1,Income: PIR below 2,,,,0.2,0.3,837,2017-2018,0.900466562986003
Branch perfluorooctanoic acid isomers (ng/mL),335-67-1,Race/eth: Hispanic,,,,0.1,0.2,473,2017-2018,0.900466562986003
Branch perfluorooctanoic acid isomers (ng/mL),335-67-1,Race/eth: Non-hispanic black,,,,0.1,0.2,430,2017-2018,0.900466562986003
Branch perfluorooctanoic acid isomers (ng/mL),335-67-1,Race/eth: Non-hispanic white,,,,0.2,0.3,667,2017-2018,0.900466562986003
Branch perfluorooctanoic acid isomers (ng/mL),335-67-1,Race/eth: Other,,,,0.2,0.3,359,2017-2018,0.900466562986003
Linear perfluorooctanoate (ng/mL),335-67-1,Gender: female,1.16495167691427,1.2,1.9,3.7,6.9,977,2017-2018,0.00362882322446864
Linear perfluorooctanoate (ng/mL),335-67-1,Gender: male,1.51133158171752,1.5,2.1,3.7,7.7,952,2017-2018,0.00362882322446864
Linear perfluorooctanoate (ng/mL),335-67-1,Income: Missing,1.14560872718023,1.2,1.8,3.6,5.5,841,2017-2018,0.00362882322446864
Linear perfluorooctanoate (ng/mL),335-67-1,Income: PIR above 2,1.19116550492848,1.4,1.9,3.6,6.7,251,2017-2018,0.00362882322446864
Linear perfluorooctanoate (ng/mL),335-67-1,Income: PIR below 2,1.45783442889311,1.5,2.1,4.1,7.7,837,2017-2018,0.00362882322446864
Linear perfluorooctanoate (ng/mL),335-67-1,Race/eth: Hispanic,1.07787062287711,1.2,1.6,2.9,5.3,473,2017-2018,0.00362882322446864
Linear perfluorooctanoate (ng/mL),335-67-1,Race/eth: Non-hispanic black,1.29042619517725,1.2,1.7,3.3,5.3,430,2017-2018,0.00362882322446864
Linear perfluorooctanoate (ng/mL),335-67-1,Race/eth: Non-hispanic white,1.44851342181768,1.5,2.2,3.7,7.7,667,2017-2018,0.00362882322446864
Linear perfluorooctanoate (ng/mL),335-67-1,Race/eth: Other,1.09352636914805,1.2,2,5.4,14.8,359,2017-2018,0.00362882322446864
Perfluorooctanoic acid (ng/mL),335-67-1,Gender: female,1.26159692854344,1.27,1.97,3.77,6.97,977,2017-2018,0.00570243649559357
Perfluorooctanoic acid (ng/mL),335-67-1,Gender: male,1.60529872455352,1.57,2.17,3.77,8.3,952,2017-2018,0.00570243649559357
Perfluorooctanoic acid (ng/mL),335-67-1,Income: Missing,1.24113918752744,1.27,1.87,3.67,5.7,841,2017-2018,0.00570243649559357
Perfluorooctanoic acid (ng/mL),335-67-1,Income: PIR above 2,1.29405503745894,1.5,1.97,3.67,6.77,251,2017-2018,0.00570243649559357
Perfluorooctanoic acid (ng/mL),335-67-1,Income: PIR below 2,1.55202754111997,1.57,2.27,4.17,8.3,837,2017-2018,0.00570243649559357
Perfluorooctanoic acid (ng/mL),335-67-1,Race/eth: Hispanic,1.17630087054508,1.27,1.67,2.97,5.37,473,2017-2018,0.00570243649559357
Perfluorooctanoic acid (ng/mL),335-67-1,Race/eth: Non-hispanic black,1.39022330353329,1.27,1.77,3.37,5.37,430,2017-2018,0.00570243649559357
Perfluorooctanoic acid (ng/mL),335-67-1,Race/eth: Non-hispanic white,1.54365351770237,1.57,2.27,3.77,8.3,667,2017-2018,0.00570243649559357
Perfluorooctanoic acid (ng/mL),335-67-1,Race/eth: Other,1.18611952222693,1.27,2.07,5.5,14.87,359,2017-2018,0.00570243649559357
Urinary Branched isomers of perfluorooctanoate (ng/mL),335-67-1,Gender: female,,,,,,1209,2013-2014,0.998711340206185
Urinary Branched isomers of perfluorooctanoate (ng/mL),335-67-1,Gender: male,,,,,,1119,2013-2014,0.998711340206185
Urinary Branched isomers of perfluorooctanoate (ng/mL),335-67-1,Income: Missing,,,,,,177,2013-2014,0.998711340206185
Urinary Branched isomers of perfluorooctanoate (ng/mL),335-67-1,Income: PIR above 2,,,,,,1142,2013-2014,0.998711340206185
Urinary Branched isomers of perfluorooctanoate (ng/mL),335-67-1,Income: PIR below 2,,,,,,1009,2013-2014,0.998711340206185
Urinary Branched isomers of perfluorooctanoate (ng/mL),335-67-1,Race/eth: Hispanic,,,,,,611,2013-2014,0.998711340206185
Urinary Branched isomers of perfluorooctanoate (ng/mL),335-67-1,Race/eth: Non-hispanic black,,,,,,476,2013-2014,0.998711340206185
Urinary Branched isomers of perfluorooctanoate (ng/mL),335-67-1,Race/eth: Non-hispanic white,,,,,,908,2013-2014,0.998711340206185
Urinary Branched isomers of perfluorooctanoate (ng/mL),335-67-1,Race/eth: Other,,,,,,333,2013-2014,0.998711340206185
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Gender: female,2.76740339033123,2.9,5.5,15,26.6,1399,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Gender: male,3.23082139202732,3.4,6.4,17.9,44.6,1363,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Income: Missing,3.48494669963082,3.8,7,18.5,45.7,1264,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Income: PIR above 2,3.05861955417675,3.1,5.8,22.8,31.5,337,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Income: PIR below 2,2.71557983358585,2.7,5.4,14.7,30.9,1161,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Race/eth: Hispanic,3.76114083935883,3.5,6.4,17.6,43,663,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Race/eth: Non-hispanic black,2.76106928262898,4.3,7.9,18.9,37.9,645,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Race/eth: Non-hispanic white,2.81606031330937,2.9,5.5,15.6,27.8,906,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Race/eth: Other,3.25355340881404,3,5.6,16.7,52.9,548,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Gender: female,2.76740339033123,2.9,5.5,15,26.6,1399,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Gender: male,3.23082139202732,3.4,6.4,17.9,44.6,1363,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Income: Missing,3.48494669963082,3.8,7,18.5,45.7,1264,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Income: PIR above 2,3.05861955417675,3.1,5.8,22.8,31.5,337,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Income: PIR below 2,2.71557983358585,2.7,5.4,14.7,30.9,1161,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Race/eth: Hispanic,3.76114083935883,3.5,6.4,17.6,43,663,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Race/eth: Non-hispanic black,2.76106928262898,4.3,7.9,18.9,37.9,645,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Race/eth: Non-hispanic white,2.81606031330937,2.9,5.5,15.6,27.8,906,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-oxohexyl) phthalate (ng/mL),117-81-7,Race/eth: Other,3.25355340881404,3,5.6,16.7,52.9,548,2017-2018,0.00832729905865315
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-hydroxyhexyl) phthalate (ng/mL),117-81-7,Gender: female,4.13072941298384,4.4,8.2,22,41.3,1399,2017-2018,0.00977552498189718
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-hydroxyhexyl) phthalate (ng/mL),117-81-7,Gender: male,5.06512307716735,5.2,10.6,26.7,61.1,1363,2017-2018,0.00977552498189718
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-hydroxyhexyl) phthalate (ng/mL),117-81-7,Income: Missing,5.25938823019672,5.6,11,25.9,67.7,1264,2017-2018,0.00977552498189718
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-hydroxyhexyl) phthalate (ng/mL),117-81-7,Income: PIR above 2,4.63114570537072,4.9,8.5,25.6,48.7,337,2017-2018,0.00977552498189718
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-hydroxyhexyl) phthalate (ng/mL),117-81-7,Income: PIR below 2,4.19127341635723,4.4,8.2,21.9,49.9,1161,2017-2018,0.00977552498189718
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-hydroxyhexyl) phthalate (ng/mL),117-81-7,Race/eth: Hispanic,6.00977166457668,5.1,9.8,24.4,66.7,663,2017-2018,0.00977552498189718
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-hydroxyhexyl) phthalate (ng/mL),117-81-7,Race/eth: Non-hispanic black,4.23163661792713,6.5,12.2,29.5,59.2,645,2017-2018,0.00977552498189718
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-hydroxyhexyl) phthalate (ng/mL),117-81-7,Race/eth: Non-hispanic white,4.30235755986902,4.5,8.4,23.9,41.3,906,2017-2018,0.00977552498189718
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethyl-5-hydroxyhexyl) phthalate (ng/mL),117-81-7,Race/eth: Other,4.83586749814929,4.2,7.9,25.8,87.7,548,2017-2018,0.00977552498189718
Crotonaldehyde (ng/mL),4170-30-3,Gender: female,,,0.159,0.334,0.549,889,2013-2014,0.664166185804962
Crotonaldehyde (ng/mL),4170-30-3,Gender: male,,,0.164,0.359,0.717,844,2013-2014,0.664166185804962
Crotonaldehyde (ng/mL),4170-30-3,Income: Missing,,,0.185,0.318,0.378,112,2013-2014,0.664166185804962
Crotonaldehyde (ng/mL),4170-30-3,Income: PIR above 2,,,0.172,0.359,0.668,809,2013-2014,0.664166185804962
Crotonaldehyde (ng/mL),4170-30-3,Income: PIR below 2,,,0.151,0.332,0.549,812,2013-2014,0.664166185804962
Crotonaldehyde (ng/mL),4170-30-3,Race/eth: Hispanic,,,0.181,0.485,1.08,444,2013-2014,0.664166185804962
Crotonaldehyde (ng/mL),4170-30-3,Race/eth: Non-hispanic black,,,0.177,0.337,0.481,299,2013-2014,0.664166185804962
Crotonaldehyde (ng/mL),4170-30-3,Race/eth: Non-hispanic white,,,0.151,0.302,0.548,750,2013-2014,0.664166185804962
Crotonaldehyde (ng/mL),4170-30-3,Race/eth: Other,,,0.172,0.412,0.61,240,2013-2014,0.664166185804962
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethylhexyl) phthalate (ng/mL),117-81-7,Gender: female,,,1.6,4.2,11,1399,2017-2018,0.437726285300507
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethylhexyl) phthalate (ng/mL),117-81-7,Gender: male,,0.9,1.8,5.7,16,1363,2017-2018,0.437726285300507
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethylhexyl) phthalate (ng/mL),117-81-7,Income: Missing,,1,1.9,5.2,11.6,1264,2017-2018,0.437726285300507
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethylhexyl) phthalate (ng/mL),117-81-7,Income: PIR above 2,,0.8,2,7.2,12.3,337,2017-2018,0.437726285300507
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethylhexyl) phthalate (ng/mL),117-81-7,Income: PIR below 2,,,1.4,4.5,13,1161,2017-2018,0.437726285300507
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethylhexyl) phthalate (ng/mL),117-81-7,Race/eth: Hispanic,,1,2.1,6.5,11.8,663,2017-2018,0.437726285300507
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethylhexyl) phthalate (ng/mL),117-81-7,Race/eth: Non-hispanic black,,1.3,2.5,6.6,14.2,645,2017-2018,0.437726285300507
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethylhexyl) phthalate (ng/mL),117-81-7,Race/eth: Non-hispanic white,,,1.4,4.2,13,906,2017-2018,0.437726285300507
Di(2-ethylhexyl) phthalate metabolite: Mono-(2-ethylhexyl) phthalate (ng/mL),117-81-7,Race/eth: Other,,1,2,5.9,13.4,548,2017-2018,0.437726285300507
Benzene metabolite: N-Acetyl-S-(phenyl)-L-cysteine (ng/mL),71-43-2,Gender: female,,,1.02,2.88,6.34,1516,2015-2016,0.527031509121061
Benzene metabolite: N-Acetyl-S-(phenyl)-L-cysteine (ng/mL),71-43-2,Gender: male,,0.65,1.23,3.25,7.45,1499,2015-2016,0.527031509121061
Benzene metabolite: N-Acetyl-S-(phenyl)-L-cysteine (ng/mL),71-43-2,Income: Missing,,0.627,0.965,3.1,4.36,311,2015-2016,0.527031509121061
Benzene metabolite: N-Acetyl-S-(phenyl)-L-cysteine (ng/mL),71-43-2,Income: PIR above 2,,,1.18,2.9,7.51,1433,2015-2016,0.527031509121061
Benzene metabolite: N-Acetyl-S-(phenyl)-L-cysteine (ng/mL),71-43-2,Income: PIR below 2,,,1.13,3.19,7.45,1271,2015-2016,0.527031509121061
Benzene metabolite: N-Acetyl-S-(phenyl)-L-cysteine (ng/mL),71-43-2,Race/eth: Hispanic,,0.604,1.18,3.8,8.52,970,2015-2016,0.527031509121061
Benzene metabolite: N-Acetyl-S-(phenyl)-L-cysteine (ng/mL),71-43-2,Race/eth: Non-hispanic black,,0.616,1.21,2.54,4.79,656,2015-2016,0.527031509121061
Benzene metabolite: N-Acetyl-S-(phenyl)-L-cysteine (ng/mL),71-43-2,Race/eth: Non-hispanic white,,,1.09,3.04,4.98,912,2015-2016,0.527031509121061
Benzene metabolite: N-Acetyl-S-(phenyl)-L-cysteine (ng/mL),71-43-2,Race/eth: Other,,,1.03,3.4,6.36,477,2015-2016,0.527031509121061
Formaldehyde (nmol/g Hb),50-00-0,Gender: female,127.720427590279,130,139,155,169,1206,2015-2016,0
Formaldehyde (nmol/g Hb),50-00-0,Gender: male,127.940290649307,129,138,155,166,1166,2015-2016,0
Formaldehyde (nmol/g Hb),50-00-0,Income: Missing,128.370457462257,130,137,154,160,235,2015-2016,0
Formaldehyde (nmol/g Hb),50-00-0,Income: PIR above 2,125.776419684704,127,138,155,178,1094,2015-2016,0
Formaldehyde (nmol/g Hb),50-00-0,Income: PIR below 2,128.891458038948,130,139,156,166,1043,2015-2016,0
Formaldehyde (nmol/g Hb),50-00-0,Race/eth: Hispanic,129.204036973329,129,139,159,190,784,2015-2016,0
Formaldehyde (nmol/g Hb),50-00-0,Race/eth: Non-hispanic black,120.702737675963,127,136,153,164,471,2015-2016,0
Formaldehyde (nmol/g Hb),50-00-0,Race/eth: Non-hispanic white,128.259295682321,130,139,155,166,747,2015-2016,0
Formaldehyde (nmol/g Hb),50-00-0,Race/eth: Other,126.444274404425,128,136,152,165,370,2015-2016,0
"p,p'-DDT (ng/g)",50-29-3,Gender: female,,,,0.1464,0.4168,1006,2003-2004,0.753180661577608
"p,p'-DDT (ng/g)",50-29-3,Gender: male,,,,0.1083,0.6113,959,2003-2004,0.753180661577608
"p,p'-DDT (ng/g)",50-29-3,Income: Missing,,,0.0344,0.1433,2.1493,105,2003-2004,0.753180661577608
"p,p'-DDT (ng/g)",50-29-3,Income: PIR above 2,,,,0.1667,1.682,937,2003-2004,0.753180661577608
"p,p'-DDT (ng/g)",50-29-3,Income: PIR below 2,,,,0.1019,0.3443,923,2003-2004,0.753180661577608
"p,p'-DDT (ng/g)",50-29-3,Race/eth: Hispanic,,,0.0607,0.2405,2.4563,526,2003-2004,0.753180661577608
"p,p'-DDT (ng/g)",50-29-3,Race/eth: Non-hispanic black,,,0.0475,0.2013,0.8768,479,2003-2004,0.753180661577608
"p,p'-DDT (ng/g)",50-29-3,Race/eth: Non-hispanic white,,,,0.0845,0.215,881,2003-2004,0.753180661577608
"p,p'-DDT (ng/g)",50-29-3,Race/eth: Other,,,0.0686,0.3871,4.6345,79,2003-2004,0.753180661577608
"p,p'-DDT Lipid Adj (ng/g)",50-29-3,Gender: female,,,,21,73.4,1006,2003-2004,0.753180661577608
"p,p'-DDT Lipid Adj (ng/g)",50-29-3,Gender: male,,,,15.2,92.5,959,2003-2004,0.753180661577608
"p,p'-DDT Lipid Adj (ng/g)",50-29-3,Income: Missing,,,8.5,21.6,348,105,2003-2004,0.753180661577608
"p,p'-DDT Lipid Adj (ng/g)",50-29-3,Income: PIR above 2,,,,26.7,274,937,2003-2004,0.753180661577608
"p,p'-DDT Lipid Adj (ng/g)",50-29-3,Income: PIR below 2,,,,15.8,56.6,923,2003-2004,0.753180661577608
"p,p'-DDT Lipid Adj (ng/g)",50-29-3,Race/eth: Hispanic,,,9.2,35.5,396,526,2003-2004,0.753180661577608
"p,p'-DDT Lipid Adj (ng/g)",50-29-3,Race/eth: Non-hispanic black,,,9,31.5,154,479,2003-2004,0.753180661577608
"p,p'-DDT Lipid Adj (ng/g)",50-29-3,Race/eth: Non-hispanic white,,,,12.9,38.5,881,2003-2004,0.753180661577608
"p,p'-DDT Lipid Adj (ng/g)",50-29-3,Race/eth: Other,,,14.1,71.4,575,79,2003-2004,0.753180661577608
Acrolein metabolite: N-acetyl-S-(2-Carboxyethyl)-L-cysteine (ng/mL),107-02-8,Gender: female,79.2977219937643,79.3,150,435,764,1516,2015-2016,0.00398009950248756
Acrolein metabolite: N-acetyl-S-(2-Carboxyethyl)-L-cysteine (ng/mL),107-02-8,Gender: male,105.134050755104,108,192,515,929,1499,2015-2016,0.00398009950248756
Acrolein metabolite: N-acetyl-S-(2-Carboxyethyl)-L-cysteine (ng/mL),107-02-8,Income: Missing,97.6324409746023,99.9,189,590,1070,311,2015-2016,0.00398009950248756
Acrolein metabolite: N-acetyl-S-(2-Carboxyethyl)-L-cysteine (ng/mL),107-02-8,Income: PIR above 2,97.7802813919439,101,190,489,1050,1433,2015-2016,0.00398009950248756
Acrolein metabolite: N-acetyl-S-(2-Carboxyethyl)-L-cysteine (ng/mL),107-02-8,Income: PIR below 2,86.5307023640453,90.8,159,451,764,1271,2015-2016,0.00398009950248756
Acrolein metabolite: N-acetyl-S-(2-Carboxyethyl)-L-cysteine (ng/mL),107-02-8,Race/eth: Hispanic,87.293415409042,90.6,158,349,572,970,2015-2016,0.00398009950248756
Acrolein metabolite: N-acetyl-S-(2-Carboxyethyl)-L-cysteine (ng/mL),107-02-8,Race/eth: Non-hispanic black,148.098362017693,145,260,675,1200,656,2015-2016,0.00398009950248756
Acrolein metabolite: N-acetyl-S-(2-Carboxyethyl)-L-cysteine (ng/mL),107-02-8,Race/eth: Non-hispanic white,83.6195876742826,90.7,167,473,794,912,2015-2016,0.00398009950248756
Acrolein metabolite: N-acetyl-S-(2-Carboxyethyl)-L-cysteine (ng/mL),107-02-8,Race/eth: Other,76.3828727422305,80.8,149,308,640,477,2015-2016,0.00398009950248756
N-Nitrosodiethylamine (NDEA) (ng/L),55-18-5,Gender: female,,,,,,1232,2013-2014,0.995951417004049
N-Nitrosodiethylamine (NDEA) (ng/L),55-18-5,Gender: male,,,,,,1238,2013-2014,0.995951417004049
N-Nitrosodiethylamine (NDEA) (ng/L),55-18-5,Income: Missing,,,,,,180,2013-2014,0.995951417004049
N-Nitrosodiethylamine (NDEA) (ng/L),55-18-5,Income: PIR above 2,,,,,,1178,2013-2014,0.995951417004049
N-Nitrosodiethylamine (NDEA) (ng/L),55-18-5,Income: PIR below 2,,,,,,1112,2013-2014,0.995951417004049
N-Nitrosodiethylamine (NDEA) (ng/L),55-18-5,Race/eth: Hispanic,,,,,,678,2013-2014,0.995951417004049
N-Nitrosodiethylamine (NDEA) (ng/L),55-18-5,Race/eth: Non-hispanic black,,,,,,522,2013-2014,0.995951417004049
N-Nitrosodiethylamine (NDEA) (ng/L),55-18-5,Race/eth: Non-hispanic white,,,,,,888,2013-2014,0.995951417004049
N-Nitrosodiethylamine (NDEA) (ng/L),55-18-5,Race/eth: Other,,,,,,382,2013-2014,0.995951417004049
Blood Carbon Tetrachloride (ng/mL),56-23-5,Gender: female,,,,,,1467,2017-2018,0.998945518453427
Blood Carbon Tetrachloride (ng/mL),56-23-5,Gender: male,,,,,,1378,2017-2018,0.998945518453427
Blood Carbon Tetrachloride (ng/mL),56-23-5,Income: Missing,,,,,,1189,2017-2018,0.998945518453427
Blood Carbon Tetrachloride (ng/mL),56-23-5,Income: PIR above 2,,,,,,376,2017-2018,0.998945518453427
Blood Carbon Tetrachloride (ng/mL),56-23-5,Income: PIR below 2,,,,,,1280,2017-2018,0.998945518453427
Blood Carbon Tetrachloride (ng/mL),56-23-5,Race/eth: Hispanic,,,,,,675,2017-2018,0.998945518453427
Blood Carbon Tetrachloride (ng/mL),56-23-5,Race/eth: Non-hispanic black,,,,,,630,2017-2018,0.998945518453427
Blood Carbon Tetrachloride (ng/mL),56-23-5,Race/eth: Non-hispanic white,,,,,,972,2017-2018,0.998945518453427
Blood Carbon Tetrachloride (ng/mL),56-23-5,Race/eth: Other,,,,,,568,2017-2018,0.998945518453427
"2,3,4,7,8-Pentachlorodibenzofuran (fg/g)",57117-31-4,Gender: female,,,,84.4,132.5,951,2003-2004,0.767504008551577
"2,3,4,7,8-Pentachlorodibenzofuran (fg/g)",57117-31-4,Gender: male,,,38.8,78.9,137.3,920,2003-2004,0.767504008551577
"2,3,4,7,8-Pentachlorodibenzofuran (fg/g)",57117-31-4,Income: Missing,,,40.6,85.9,123.2,90,2003-2004,0.767504008551577
"2,3,4,7,8-Pentachlorodibenzofuran (fg/g)",57117-31-4,Income: PIR above 2,,,,84.1,157,911,2003-2004,0.767504008551577
"2,3,4,7,8-Pentachlorodibenzofuran (fg/g)",57117-31-4,Income: PIR below 2,,,39.1,78.9,126.2,870,2003-2004,0.767504008551577
"2,3,4,7,8-Pentachlorodibenzofuran (fg/g)",57117-31-4,Race/eth: Hispanic,,,,59.4,105.1,484,2003-2004,0.767504008551577
"2,3,4,7,8-Pentachlorodibenzofuran (fg/g)",57117-31-4,Race/eth: Non-hispanic black,,,,97.4,173.2,443,2003-2004,0.767504008551577
"2,3,4,7,8-Pentachlorodibenzofuran (fg/g)",57117-31-4,Race/eth: Non-hispanic white,,,41.6,84.4,132.5,859,2003-2004,0.767504008551577
"2,3,4,7,8-Pentachlorodibenzofuran (fg/g)",57117-31-4,Race/eth: Other,,,,65.3,86.4,85,2003-2004,0.767504008551577
"2,3,4,7,8-Pentachlorodibenzofuran Lipid Adj (pg/g)",57117-31-4,Gender: female,,,,12.6,17.5,951,2003-2004,0.767504008551577
"2,3,4,7,8-Pentachlorodibenzofuran Lipid Adj (pg/g)",57117-31-4,Gender: male,,,7,12.2,20.2,920,2003-2004,0.767504008551577
"2,3,4,7,8-Pentachlorodibenzofuran Lipid Adj (pg/g)",57117-31-4,Income: Missing,,,6.8,13.2,15.6,90,2003-2004,0.767504008551577
"2,3,4,7,8-Pentachlorodibenzofuran Lipid Adj (pg/g)",57117-31-4,Income: PIR above 2,,,,12.7,20.9,911,2003-2004,0.767504008551577
"2,3,4,7,8-Pentachlorodibenzofuran Lipid Adj (pg/g)",57117-31-4,Income: PIR below 2,,,7,11.6,18.1,870,2003-2004,0.767504008551577
"2,3,4,7,8-Pentachlorodibenzofuran Lipid Adj (pg/g)",57117-31-4,Race/eth: Hispanic,,,,10,12.6,484,2003-2004,0.767504008551577
"2,3,4,7,8-Pentachlorodibenzofuran Lipid Adj (pg/g)",57117-31-4,Race/eth: Non-hispanic black,,,,15.9,26.8,443,2003-2004,0.767504008551577
"2,3,4,7,8-Pentachlorodibenzofuran Lipid Adj (pg/g)",57117-31-4,Race/eth: Non-hispanic white,,,7.2,12.8,18.1,859,2003-2004,0.767504008551577
"2,3,4,7,8-Pentachlorodibenzofuran Lipid Adj (pg/g)",57117-31-4,Race/eth: Other,,,,10.4,16,85,2003-2004,0.767504008551577
"3,3',4,4',5-Pentachlorobiphenyl (pncb) (pg/g)",57465-28-8,Gender: female,,89.9,179.8,558.6,1343.7,948,2003-2004,0.502150537634409
"3,3',4,4',5-Pentachlorobiphenyl (pncb) (pg/g)",57465-28-8,Gender: male,,,145.1,359.9,890.6,912,2003-2004,0.502150537634409
"3,3',4,4',5-Pentachlorobiphenyl (pncb) (pg/g)",57465-28-8,Income: Missing,,87.1,166.8,558.6,1593.4,90,2003-2004,0.502150537634409
"3,3',4,4',5-Pentachlorobiphenyl (pncb) (pg/g)",57465-28-8,Income: PIR above 2,,,151.5,609.2,1612.2,905,2003-2004,0.502150537634409
"3,3',4,4',5-Pentachlorobiphenyl (pncb) (pg/g)",57465-28-8,Income: PIR below 2,,90.1,158.1,369.6,908.3,865,2003-2004,0.502150537634409
"3,3',4,4',5-Pentachlorobiphenyl (pncb) (pg/g)",57465-28-8,Race/eth: Hispanic,,93,151.6,326.3,1148.9,479,2003-2004,0.502150537634409
"3,3',4,4',5-Pentachlorobiphenyl (pncb) (pg/g)",57465-28-8,Race/eth: Non-hispanic black,,,141.9,975.6,2977.3,441,2003-2004,0.502150537634409
"3,3',4,4',5-Pentachlorobiphenyl (pncb) (pg/g)",57465-28-8,Race/eth: Non-hispanic white,,78.1,157.8,439.1,1086.1,855,2003-2004,0.502150537634409
"3,3',4,4',5-Pentachlorobiphenyl (pncb) (pg/g)",57465-28-8,Race/eth: Other,,113.6,196,662.5,877.8,85,2003-2004,0.502150537634409
"3,3',4,4',5-Pentachlorobiphenyl (pncb) Lipid Adj (pg/g)",57465-28-8,Gender: female,,15.7,27.6,82.5,191,948,2003-2004,0.502150537634409
"3,3',4,4',5-Pentachlorobiphenyl (pncb) Lipid Adj (pg/g)",57465-28-8,Gender: male,,,21.8,51.5,132,912,2003-2004,0.502150537634409
"3,3',4,4',5-Pentachlorobiphenyl (pncb) Lipid Adj (pg/g)",57465-28-8,Income: Missing,,14.8,20.8,92.7,230,90,2003-2004,0.502150537634409
"3,3',4,4',5-Pentachlorobiphenyl (pncb) Lipid Adj (pg/g)",57465-28-8,Income: PIR above 2,,,24.5,84.4,191,905,2003-2004,0.502150537634409
"3,3',4,4',5-Pentachlorobiphenyl (pncb) Lipid Adj (pg/g)",57465-28-8,Income: PIR below 2,,15.4,25,60.4,120,865,2003-2004,0.502150537634409
"3,3',4,4',5-Pentachlorobiphenyl (pncb) Lipid Adj (pg/g)",57465-28-8,Race/eth: Hispanic,,15.5,25.2,46.7,123,479,2003-2004,0.502150537634409
"3,3',4,4',5-Pentachlorobiphenyl (pncb) Lipid Adj (pg/g)",57465-28-8,Race/eth: Non-hispanic black,,,23.5,142,550,441,2003-2004,0.502150537634409
"3,3',4,4',5-Pentachlorobiphenyl (pncb) Lipid Adj (pg/g)",57465-28-8,Race/eth: Non-hispanic white,,14.6,24.3,64.7,120,855,2003-2004,0.502150537634409
"3,3',4,4',5-Pentachlorobiphenyl (pncb) Lipid Adj (pg/g)",57465-28-8,Race/eth: Other,,18.6,31.9,99.2,134,85,2003-2004,0.502150537634409
Gamma-hexachlorocyclohexane (ng/g),58-89-9,Gender: female,,,,,,1008,2003-2004,0.995918367346939
Gamma-hexachlorocyclohexane (ng/g),58-89-9,Gender: male,,,,,,952,2003-2004,0.995918367346939
Gamma-hexachlorocyclohexane (ng/g),58-89-9,Income: Missing,,,,,,103,2003-2004,0.995918367346939
Gamma-hexachlorocyclohexane (ng/g),58-89-9,Income: PIR above 2,,,,,,939,2003-2004,0.995918367346939
Gamma-hexachlorocyclohexane (ng/g),58-89-9,Income: PIR below 2,,,,,,918,2003-2004,0.995918367346939
Gamma-hexachlorocyclohexane (ng/g),58-89-9,Race/eth: Hispanic,,,,,,526,2003-2004,0.995918367346939
Gamma-hexachlorocyclohexane (ng/g),58-89-9,Race/eth: Non-hispanic black,,,,,,479,2003-2004,0.995918367346939
Gamma-hexachlorocyclohexane (ng/g),58-89-9,Race/eth: Non-hispanic white,,,,,,875,2003-2004,0.995918367346939
Gamma-hexachlorocyclohexane (ng/g),58-89-9,Race/eth: Other,,,,,,80,2003-2004,0.995918367346939
Gamma-hexachlorocyclohexane Lipid Adj (ng/g),58-89-9,Gender: female,,,,,,1008,2003-2004,0.995918367346939
Gamma-hexachlorocyclohexane Lipid Adj (ng/g),58-89-9,Gender: male,,,,,,952,2003-2004,0.995918367346939
Gamma-hexachlorocyclohexane Lipid Adj (ng/g),58-89-9,Income: Missing,,,,,,103,2003-2004,0.995918367346939
Gamma-hexachlorocyclohexane Lipid Adj (ng/g),58-89-9,Income: PIR above 2,,,,,,939,2003-2004,0.995918367346939
Gamma-hexachlorocyclohexane Lipid Adj (ng/g),58-89-9,Income: PIR below 2,,,,,,918,2003-2004,0.995918367346939
Gamma-hexachlorocyclohexane Lipid Adj (ng/g),58-89-9,Race/eth: Hispanic,,,,,,526,2003-2004,0.995918367346939
Gamma-hexachlorocyclohexane Lipid Adj (ng/g),58-89-9,Race/eth: Non-hispanic black,,,,,,479,2003-2004,0.995918367346939
Gamma-hexachlorocyclohexane Lipid Adj (ng/g),58-89-9,Race/eth: Non-hispanic white,,,,,,875,2003-2004,0.995918367346939
Gamma-hexachlorocyclohexane Lipid Adj (ng/g),58-89-9,Race/eth: Other,,,,,,80,2003-2004,0.995918367346939
N-Nitrosomorpholine (NMOR) (ng/L),59-89-2,Gender: female,,,,8.34,16.5,1205,2013-2014,0.948406040268456
N-Nitrosomorpholine (NMOR) (ng/L),59-89-2,Gender: male,,,,,18.6,1179,2013-2014,0.948406040268456
N-Nitrosomorpholine (NMOR) (ng/L),59-89-2,Income: Missing,,,,,13.7,168,2013-2014,0.948406040268456
N-Nitrosomorpholine (NMOR) (ng/L),59-89-2,Income: PIR above 2,,,,8.95,18.7,1132,2013-2014,0.948406040268456
N-Nitrosomorpholine (NMOR) (ng/L),59-89-2,Income: PIR below 2,,,,,16.5,1084,2013-2014,0.948406040268456
N-Nitrosomorpholine (NMOR) (ng/L),59-89-2,Race/eth: Hispanic,,,,,12.1,646,2013-2014,0.948406040268456
N-Nitrosomorpholine (NMOR) (ng/L),59-89-2,Race/eth: Non-hispanic black,,,,8.83,17.6,517,2013-2014,0.948406040268456
N-Nitrosomorpholine (NMOR) (ng/L),59-89-2,Race/eth: Non-hispanic white,,,,7.88,18.6,854,2013-2014,0.948406040268456
N-Nitrosomorpholine (NMOR) (ng/L),59-89-2,Race/eth: Other,,,,8.02,14.4,367,2013-2014,0.948406040268456
Blood Vinyl Bromide (ng/mL),593-60-2,Gender: female,,,,,,1473,2017-2018,1
Blood Vinyl Bromide (ng/mL),593-60-2,Gender: male,,,,,,1392,2017-2018,1
Blood Vinyl Bromide (ng/mL),593-60-2,Income: Missing,,,,,,1197,2017-2018,1
Blood Vinyl Bromide (ng/mL),593-60-2,Income: PIR above 2,,,,,,378,2017-2018,1
Blood Vinyl Bromide (ng/mL),593-60-2,Income: PIR below 2,,,,,,1290,2017-2018,1
Blood Vinyl Bromide (ng/mL),593-60-2,Race/eth: Hispanic,,,,,,682,2017-2018,1
Blood Vinyl Bromide (ng/mL),593-60-2,Race/eth: Non-hispanic black,,,,,,636,2017-2018,1
Blood Vinyl Bromide (ng/mL),593-60-2,Race/eth: Non-hispanic white,,,,,,977,2017-2018,1
Blood Vinyl Bromide (ng/mL),593-60-2,Race/eth: Other,,,,,,570,2017-2018,1
Dieldrin (ng/g),60-57-1,Gender: female,,,0.0516,0.1103,0.3436,998,2003-2004,0.70030737704918
Dieldrin (ng/g),60-57-1,Gender: male,,,0.0605,0.1471,0.3541,954,2003-2004,0.70030737704918
Dieldrin (ng/g),60-57-1,Income: Missing,,,0.0548,0.0918,0.168,101,2003-2004,0.70030737704918
Dieldrin (ng/g),60-57-1,Income: PIR above 2,,,0.0384,0.1141,0.1916,927,2003-2004,0.70030737704918
Dieldrin (ng/g),60-57-1,Income: PIR below 2,,,0.0609,0.1471,0.4776,924,2003-2004,0.70030737704918
Dieldrin (ng/g),60-57-1,Race/eth: Hispanic,,,,0.1055,0.1806,521,2003-2004,0.70030737704918
Dieldrin (ng/g),60-57-1,Race/eth: Non-hispanic black,,,0.0517,0.103,0.1788,477,2003-2004,0.70030737704918
Dieldrin (ng/g),60-57-1,Race/eth: Non-hispanic white,,,0.0594,0.1388,0.3541,876,2003-2004,0.70030737704918
Dieldrin (ng/g),60-57-1,Race/eth: Other,,,0.0567,0.1554,0.3641,78,2003-2004,0.70030737704918
Dieldrin Lipid Adj (ng/g),60-57-1,Gender: female,,,8.7,16.9,51.9,998,2003-2004,0.70030737704918
Dieldrin Lipid Adj (ng/g),60-57-1,Gender: male,,,9.3,21.9,60.5,954,2003-2004,0.70030737704918
Dieldrin Lipid Adj (ng/g),60-57-1,Income: Missing,,,9.3,14.9,23.2,101,2003-2004,0.70030737704918
Dieldrin Lipid Adj (ng/g),60-57-1,Income: PIR above 2,,,8.1,17,26,927,2003-2004,0.70030737704918
Dieldrin Lipid Adj (ng/g),60-57-1,Income: PIR below 2,,,9.5,21.5,76.5,924,2003-2004,0.70030737704918
Dieldrin Lipid Adj (ng/g),60-57-1,Race/eth: Hispanic,,,,14.6,29,521,2003-2004,0.70030737704918
Dieldrin Lipid Adj (ng/g),60-57-1,Race/eth: Non-hispanic black,,,8.8,15.9,25.7,477,2003-2004,0.70030737704918
Dieldrin Lipid Adj (ng/g),60-57-1,Race/eth: Non-hispanic white,,,9.3,19.5,60.5,876,2003-2004,0.70030737704918
Dieldrin Lipid Adj (ng/g),60-57-1,Race/eth: Other,,,9.5,26,51.9,78,2003-2004,0.70030737704918
Ethylbenzene metabolite: Phenylglyoxylic acid (ng/mL),100-41-4,Gender: female,172.663627491134,178,322,627,962,1516,2015-2016,0.00730169266511782
Ethylbenzene metabolite: Phenylglyoxylic acid (ng/mL),100-41-4,Gender: male,216.95200236043,236,386,695,1340,1497,2015-2016,0.00730169266511782
Ethylbenzene metabolite: Phenylglyoxylic acid (ng/mL),100-41-4,Income: Missing,214.054734033507,216,398,891,1340,311,2015-2016,0.00730169266511782
Ethylbenzene metabolite: Phenylglyoxylic acid (ng/mL),100-41-4,Income: PIR above 2,194.722609881618,207,352,667,1520,1432,2015-2016,0.00730169266511782
Ethylbenzene metabolite: Phenylglyoxylic acid (ng/mL),100-41-4,Income: PIR below 2,189.10097638876,197,352,645,823,1270,2015-2016,0.00730169266511782
Ethylbenzene metabolite: Phenylglyoxylic acid (ng/mL),100-41-4,Race/eth: Hispanic,193.240865174905,196,312,559,977,969,2015-2016,0.00730169266511782
Ethylbenzene metabolite: Phenylglyoxylic acid (ng/mL),100-41-4,Race/eth: Non-hispanic black,248.995823815423,254,415,849,1840,656,2015-2016,0.00730169266511782
Ethylbenzene metabolite: Phenylglyoxylic acid (ng/mL),100-41-4,Race/eth: Non-hispanic white,171.611027651627,205,356,692,1050,911,2015-2016,0.00730169266511782
Ethylbenzene metabolite: Phenylglyoxylic acid (ng/mL),100-41-4,Race/eth: Other,173.427035049003,178,314,549,1280,477,2015-2016,0.00730169266511782
"3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (pg/mL)",62450-06-0,Gender: female,,,,,1.08,1282,2013-2014,0.983261969637991
"3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (pg/mL)",62450-06-0,Gender: male,,,,,1.98,1287,2013-2014,0.983261969637991
"3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (pg/mL)",62450-06-0,Income: Missing,,,,,1.04,180,2013-2014,0.983261969637991
"3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (pg/mL)",62450-06-0,Income: PIR above 2,,,,,1.08,1245,2013-2014,0.983261969637991
"3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (pg/mL)",62450-06-0,Income: PIR below 2,,,,,1.77,1144,2013-2014,0.983261969637991
"3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (pg/mL)",62450-06-0,Race/eth: Hispanic,,,,,0.89,681,2013-2014,0.983261969637991
"3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (pg/mL)",62450-06-0,Race/eth: Non-hispanic black,,,,,2.09,555,2013-2014,0.983261969637991
"3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (pg/mL)",62450-06-0,Race/eth: Non-hispanic white,,,,,1.78,945,2013-2014,0.983261969637991
"3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (pg/mL)",62450-06-0,Race/eth: Other,,,,,0.89,388,2013-2014,0.983261969637991
"Blood 1,1,1,2-tetrachloroethane (ng/mL)",630-20-6,Gender: female,,,,,,1473,2017-2018,1
"Blood 1,1,1,2-tetrachloroethane (ng/mL)",630-20-6,Gender: male,,,,,,1393,2017-2018,1
"Blood 1,1,1,2-tetrachloroethane (ng/mL)",630-20-6,Income: Missing,,,,,,1197,2017-2018,1
"Blood 1,1,1,2-tetrachloroethane (ng/mL)",630-20-6,Income: PIR above 2,,,,,,378,2017-2018,1
"Blood 1,1,1,2-tetrachloroethane (ng/mL)",630-20-6,Income: PIR below 2,,,,,,1291,2017-2018,1
"Blood 1,1,1,2-tetrachloroethane (ng/mL)",630-20-6,Race/eth: Hispanic,,,,,,682,2017-2018,1
"Blood 1,1,1,2-tetrachloroethane (ng/mL)",630-20-6,Race/eth: Non-hispanic black,,,,,,637,2017-2018,1
"Blood 1,1,1,2-tetrachloroethane (ng/mL)",630-20-6,Race/eth: Non-hispanic white,,,,,,977,2017-2018,1
"Blood 1,1,1,2-tetrachloroethane (ng/mL)",630-20-6,Race/eth: Other,,,,,,570,2017-2018,1
Blood Chloroform (pg/mL),67-66-3,Gender: female,,8,14,32,74,1468,2017-2018,0.503149055283415
Blood Chloroform (pg/mL),67-66-3,Gender: male,,8,14,35,74,1390,2017-2018,0.503149055283415
Blood Chloroform (pg/mL),67-66-3,Income: Missing,,,13,35,74,1196,2017-2018,0.503149055283415
Blood Chloroform (pg/mL),67-66-3,Income: PIR above 2,,8,14,35,56,375,2017-2018,0.503149055283415
Blood Chloroform (pg/mL),67-66-3,Income: PIR below 2,,8,14,34,74,1287,2017-2018,0.503149055283415
Blood Chloroform (pg/mL),67-66-3,Race/eth: Hispanic,,,12,31,49,678,2017-2018,0.503149055283415
Blood Chloroform (pg/mL),67-66-3,Race/eth: Non-hispanic black,,9,16,39,73,635,2017-2018,0.503149055283415
Blood Chloroform (pg/mL),67-66-3,Race/eth: Non-hispanic white,,,14,34,89,976,2017-2018,0.503149055283415
Blood Chloroform (pg/mL),67-66-3,Race/eth: Other,,8,15,43,56,569,2017-2018,0.503149055283415
Blood Hexachloroethane (ng/mL),67-72-1,Gender: female,,,,,,1389,2011-2012,1
Blood Hexachloroethane (ng/mL),67-72-1,Gender: male,,,,,,1399,2011-2012,1
Blood Hexachloroethane (ng/mL),67-72-1,Income: Missing,,,,,,240,2011-2012,1
Blood Hexachloroethane (ng/mL),67-72-1,Income: PIR above 2,,,,,,1238,2011-2012,1
Blood Hexachloroethane (ng/mL),67-72-1,Income: PIR below 2,,,,,,1310,2011-2012,1
Blood Hexachloroethane (ng/mL),67-72-1,Race/eth: Hispanic,,,,,,589,2011-2012,1
Blood Hexachloroethane (ng/mL),67-72-1,Race/eth: Non-hispanic black,,,,,,741,2011-2012,1
Blood Hexachloroethane (ng/mL),67-72-1,Race/eth: Non-hispanic white,,,,,,959,2011-2012,1
Blood Hexachloroethane (ng/mL),67-72-1,Race/eth: Other,,,,,,499,2011-2012,1
"2-Aminodipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-10-3,Gender: female,,,,,,1285,2013-2014,0.996889580093313
"2-Aminodipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-10-3,Gender: male,,,,,,1287,2013-2014,0.996889580093313
"2-Aminodipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-10-3,Income: Missing,,,,,,180,2013-2014,0.996889580093313
"2-Aminodipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-10-3,Income: PIR above 2,,,,,,1246,2013-2014,0.996889580093313
"2-Aminodipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-10-3,Income: PIR below 2,,,,,,1146,2013-2014,0.996889580093313
"2-Aminodipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-10-3,Race/eth: Hispanic,,,,,,683,2013-2014,0.996889580093313
"2-Aminodipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-10-3,Race/eth: Non-hispanic black,,,,,,555,2013-2014,0.996889580093313
"2-Aminodipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-10-3,Race/eth: Non-hispanic white,,,,,,946,2013-2014,0.996889580093313
"2-Aminodipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-10-3,Race/eth: Other,,,,,,388,2013-2014,0.996889580093313
"2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-11-4,Gender: female,,,,,0.65,1285,2013-2014,0.978615863141524
"2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-11-4,Gender: male,,,,,0.62,1287,2013-2014,0.978615863141524
"2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-11-4,Income: Missing,,,,,,180,2013-2014,0.978615863141524
"2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-11-4,Income: PIR above 2,,,,,0.83,1246,2013-2014,0.978615863141524
"2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-11-4,Income: PIR below 2,,,,,0.62,1146,2013-2014,0.978615863141524
"2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-11-4,Race/eth: Hispanic,,,,,0.64,683,2013-2014,0.978615863141524
"2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-11-4,Race/eth: Non-hispanic black,,,,,0.92,555,2013-2014,0.978615863141524
"2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-11-4,Race/eth: Non-hispanic white,,,,,0.62,946,2013-2014,0.978615863141524
"2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (pg/mL)",67730-11-4,Race/eth: Other,,,,,,388,2013-2014,0.978615863141524
"2-Amino-3-methyl-9H-pyrido[2,3-b]indole (pg/mL)",68006-83-7,Gender: female,,,,2.43,6.17,1283,2013-2014,0.846632931101596
"2-Amino-3-methyl-9H-pyrido[2,3-b]indole (pg/mL)",68006-83-7,Gender: male,,,,3.78,8.85,1286,2013-2014,0.846632931101596
"2-Amino-3-methyl-9H-pyrido[2,3-b]indole (pg/mL)",68006-83-7,Income: Missing,,,,3.95,6.99,179,2013-2014,0.846632931101596
"2-Amino-3-methyl-9H-pyrido[2,3-b]indole (pg/mL)",68006-83-7,Income: PIR above 2,,,,4.42,11.1,1245,2013-2014,0.846632931101596
"2-Amino-3-methyl-9H-pyrido[2,3-b]indole (pg/mL)",68006-83-7,Income: PIR below 2,,,,1.89,5.79,1145,2013-2014,0.846632931101596
"2-Amino-3-methyl-9H-pyrido[2,3-b]indole (pg/mL)",68006-83-7,Race/eth: Hispanic,,,,0.98,5.79,683,2013-2014,0.846632931101596
"2-Amino-3-methyl-9H-pyrido[2,3-b]indole (pg/mL)",68006-83-7,Race/eth: Non-hispanic black,,,,4.62,12.1,554,2013-2014,0.846632931101596
"2-Amino-3-methyl-9H-pyrido[2,3-b]indole (pg/mL)",68006-83-7,Race/eth: Non-hispanic white,,,,3.41,8.16,944,2013-2014,0.846632931101596
"2-Amino-3-methyl-9H-pyrido[2,3-b]indole (pg/mL)",68006-83-7,Race/eth: Other,,,,1.56,3.46,388,2013-2014,0.846632931101596
Blood Benzene (ng/mL),71-43-2,Gender: female,,,0.029,0.245,0.485,1460,2017-2018,0.678169014084507
Blood Benzene (ng/mL),71-43-2,Gender: male,,,0.039,0.279,0.545,1380,2017-2018,0.678169014084507
Blood Benzene (ng/mL),71-43-2,Income: Missing,,,0.072,0.382,0.734,1187,2017-2018,0.678169014084507
Blood Benzene (ng/mL),71-43-2,Income: PIR above 2,,,0.041,0.293,0.682,376,2017-2018,0.678169014084507
Blood Benzene (ng/mL),71-43-2,Income: PIR below 2,,,0.026,0.143,0.441,1277,2017-2018,0.678169014084507
Blood Benzene (ng/mL),71-43-2,Race/eth: Hispanic,,,0.026,0.111,0.238,672,2017-2018,0.678169014084507
Blood Benzene (ng/mL),71-43-2,Race/eth: Non-hispanic black,,,0.075,0.334,0.734,636,2017-2018,0.678169014084507
Blood Benzene (ng/mL),71-43-2,Race/eth: Non-hispanic white,,,0.033,0.279,0.563,972,2017-2018,0.678169014084507
Blood Benzene (ng/mL),71-43-2,Race/eth: Other,,,0.042,0.322,0.522,560,2017-2018,0.678169014084507
"Blood 1,1,1-Trichloroethane (ng/mL)",71-55-6,Gender: female,,,,,,1443,2017-2018,0.99178277956413
"Blood 1,1,1-Trichloroethane (ng/mL)",71-55-6,Gender: male,,,,,,1356,2017-2018,0.99178277956413
"Blood 1,1,1-Trichloroethane (ng/mL)",71-55-6,Income: Missing,,,,,,1182,2017-2018,0.99178277956413
"Blood 1,1,1-Trichloroethane (ng/mL)",71-55-6,Income: PIR above 2,,,,,0.025,366,2017-2018,0.99178277956413
"Blood 1,1,1-Trichloroethane (ng/mL)",71-55-6,Income: PIR below 2,,,,,,1251,2017-2018,0.99178277956413
"Blood 1,1,1-Trichloroethane (ng/mL)",71-55-6,Race/eth: Hispanic,,,,,,666,2017-2018,0.99178277956413
"Blood 1,1,1-Trichloroethane (ng/mL)",71-55-6,Race/eth: Non-hispanic black,,,,,,632,2017-2018,0.99178277956413
"Blood 1,1,1-Trichloroethane (ng/mL)",71-55-6,Race/eth: Non-hispanic white,,,,,,956,2017-2018,0.99178277956413
"Blood 1,1,1-Trichloroethane (ng/mL)",71-55-6,Race/eth: Other,,,,,0.025,545,2017-2018,0.99178277956413
"p,p'-DDE (ng/g)",72-55-9,Gender: female,1.45581020323789,1.2503,3.5536,13.6887,37.2321,1001,2003-2004,0.00306748466257669
"p,p'-DDE (ng/g)",72-55-9,Gender: male,1.44972579738727,1.302,2.8041,9.9263,28.6174,955,2003-2004,0.00306748466257669
"p,p'-DDE (ng/g)",72-55-9,Income: Missing,1.5255149197393,1.2103,4.0709,15.1609,52.1532,102,2003-2004,0.00306748466257669
"p,p'-DDE (ng/g)",72-55-9,Income: PIR above 2,1.50646149073362,1.3133,3.5717,12.9687,51.6243,927,2003-2004,0.00306748466257669
"p,p'-DDE (ng/g)",72-55-9,Income: PIR below 2,1.41836177139583,1.2642,2.8348,10.9612,22.1523,927,2003-2004,0.00306748466257669
"p,p'-DDE (ng/g)",72-55-9,Race/eth: Hispanic,1.47300652948734,2.1386,6.2772,23.3832,94.1538,522,2003-2004,0.00306748466257669
"p,p'-DDE (ng/g)",72-55-9,Race/eth: Non-hispanic black,2.50491709960431,1.2073,3.8325,16.7622,44.9984,477,2003-2004,0.00306748466257669
"p,p'-DDE (ng/g)",72-55-9,Race/eth: Non-hispanic white,1.28522418540033,1.1233,2.6307,9.7083,22.1523,879,2003-2004,0.00306748466257669
"p,p'-DDE (ng/g)",72-55-9,Race/eth: Other,2.14358813462487,2.2021,5.4898,12.5722,46.1708,78,2003-2004,0.00306748466257669
"p,p'-DDE Lipid Adj (ng/g)",72-55-9,Gender: female,235.09544573522,207,539,2010,4970,1001,2003-2004,0.00306748466257669
"p,p'-DDE Lipid Adj (ng/g)",72-55-9,Gender: male,241.119584299176,200,466,1610,4580,955,2003-2004,0.00306748466257669
"p,p'-DDE Lipid Adj (ng/g)",72-55-9,Income: Missing,256.940091413128,212,673,2310,8450,102,2003-2004,0.00306748466257669
"p,p'-DDE Lipid Adj (ng/g)",72-55-9,Income: PIR above 2,249.700430028953,216,573,2130,7520,927,2003-2004,0.00306748466257669
"p,p'-DDE Lipid Adj (ng/g)",72-55-9,Income: PIR below 2,230.648187034154,199,462,1700,3380,927,2003-2004,0.00306748466257669
"p,p'-DDE Lipid Adj (ng/g)",72-55-9,Race/eth: Hispanic,263.655858489864,338,914,3610,14600,522,2003-2004,0.00306748466257669
"p,p'-DDE Lipid Adj (ng/g)",72-55-9,Race/eth: Non-hispanic black,411.075108144311,216,614,2950,7520,477,2003-2004,0.00306748466257669
"p,p'-DDE Lipid Adj (ng/g)",72-55-9,Race/eth: Non-hispanic white,207.525719173944,177,416,1490,3350,879,2003-2004,0.00306748466257669
"p,p'-DDE Lipid Adj (ng/g)",72-55-9,Race/eth: Other,357.951411943904,314,860,2130,5730,78,2003-2004,0.00306748466257669
Blood lead replicate 1 (ug/dL),7439-92-1,Gender: female,1.19431728037611,1.2,1.8,3.6,6.3,4606,2001-2002,0.0139742873113471
Blood lead replicate 1 (ug/dL),7439-92-1,Gender: male,1.78633872428006,1.8,2.7,5.4,9.7,4339,2001-2002,0.0139742873113471
Blood lead replicate 1 (ug/dL),7439-92-1,Income: Missing,1.37194598089062,1.4,2.1,4,7,4151,2001-2002,0.0139742873113471
Blood lead replicate 1 (ug/dL),7439-92-1,Income: PIR above 2,1.56713894964593,1.5,2.5,5.2,9.4,4250,2001-2002,0.0139742873113471
Blood lead replicate 1 (ug/dL),7439-92-1,Income: PIR below 2,1.64291945729108,1.7,2.5,4.3,6.4,544,2001-2002,0.0139742873113471
Blood lead replicate 1 (ug/dL),7439-92-1,Race/eth: Hispanic,1.68436478519567,1.4,2.2,4.6,8.8,2671,2001-2002,0.0139742873113471
Blood lead replicate 1 (ug/dL),7439-92-1,Race/eth: Non-hispanic black,1.42951218506041,1.6,2.7,5.9,11.6,2174,2001-2002,0.0139742873113471
Blood lead replicate 1 (ug/dL),7439-92-1,Race/eth: Non-hispanic white,1.40906531934137,1.4,2.2,4.3,7.2,3768,2001-2002,0.0139742873113471
Blood lead replicate 1 (ug/dL),7439-92-1,Race/eth: Other,1.40972198177777,1.4,2.2,4,6.9,332,2001-2002,0.0139742873113471
Blood lead replicate 2 (ug/dL),7439-92-1,Gender: female,1.16448356021987,1.2,1.7,3.9,5.8,276,2001-2002,0.0163339382940109
Blood lead replicate 2 (ug/dL),7439-92-1,Gender: male,1.77188901389944,1.8,2.5,4.8,8.3,275,2001-2002,0.0163339382940109
Blood lead replicate 2 (ug/dL),7439-92-1,Income: Missing,1.54626769490675,1.5,2.5,6,6,30,2001-2002,0.0163339382940109
Blood lead replicate 2 (ug/dL),7439-92-1,Income: PIR above 2,1.29650130529113,1.2,2.1,4.8,10.2,190,2001-2002,0.0163339382940109
Blood lead replicate 2 (ug/dL),7439-92-1,Income: PIR below 2,1.51199415083165,1.6,2.3,4.1,6.5,331,2001-2002,0.0163339382940109
Blood lead replicate 2 (ug/dL),7439-92-1,Race/eth: Hispanic,1.4884630106483,1.4,2.1,3.1,13.1,112,2001-2002,0.0163339382940109
Blood lead replicate 2 (ug/dL),7439-92-1,Race/eth: Non-hispanic black,1.43824749226037,1.4,2.5,4.9,8.9,149,2001-2002,0.0163339382940109
Blood lead replicate 2 (ug/dL),7439-92-1,Race/eth: Non-hispanic white,1.15291670165414,1.6,2.2,4.1,6,263,2001-2002,0.0163339382940109
Blood lead replicate 2 (ug/dL),7439-92-1,Race/eth: Other,1.70663044105099,1.7,2.3,4.1,7.2,27,2001-2002,0.0163339382940109
Blood lead (ug/dL),7439-92-1,Gender: female,0.86918524730843,0.64,1.09,2.13,4.06,3534,2017-2018,0.000581057524694945
Blood lead (ug/dL),7439-92-1,Gender: male,0.665020718830005,0.85,1.37,2.81,5.6,3350,2017-2018,0.000581057524694945
Blood lead (ug/dL),7439-92-1,Income: Missing,0.749396513711278,0.73,1.21,2.34,3.84,2998,2017-2018,0.000581057524694945
Blood lead (ug/dL),7439-92-1,Income: PIR above 2,0.794248786501897,0.76,1.34,2.59,6.73,854,2017-2018,0.000581057524694945
Blood lead (ug/dL),7439-92-1,Income: PIR below 2,0.760129811449709,0.74,1.23,2.67,6.38,3032,2017-2018,0.000581057524694945
Blood lead (ug/dL),7439-92-1,Race/eth: Hispanic,0.763676349168756,0.58,1.02,2.12,5.69,1678,2017-2018,0.000581057524694945
Blood lead (ug/dL),7439-92-1,Race/eth: Non-hispanic black,0.62652417422916,0.71,1.23,2.77,5.89,1566,2017-2018,0.000581057524694945
Blood lead (ug/dL),7439-92-1,Race/eth: Non-hispanic white,0.882515339896049,0.76,1.26,2.36,4.22,2292,2017-2018,0.000581057524694945
Blood lead (ug/dL),7439-92-1,Race/eth: Other,0.777973893399188,0.87,1.45,2.76,6.45,1348,2017-2018,0.000581057524694945
"Lead, urine (ng/mL)",7439-92-1,Gender: female,0.230188532963152,0.24,0.43,0.97,2.27,1212,2017-2018,0.00623700623700624
"Lead, urine (ng/mL)",7439-92-1,Gender: male,0.30768299164431,0.32,0.55,1.32,2.09,1193,2017-2018,0.00623700623700624
"Lead, urine (ng/mL)",7439-92-1,Income: Missing,0.315064518258031,0.32,0.54,1.54,2.19,308,2017-2018,0.00623700623700624
"Lead, urine (ng/mL)",7439-92-1,Income: PIR above 2,0.243395731010039,0.25,0.48,0.95,1.73,1038,2017-2018,0.00623700623700624
"Lead, urine (ng/mL)",7439-92-1,Income: PIR below 2,0.290051019992141,0.28,0.52,1.27,3.03,1059,2017-2018,0.00623700623700624
"Lead, urine (ng/mL)",7439-92-1,Race/eth: Hispanic,0.261262663606933,0.25,0.46,0.95,1.89,591,2017-2018,0.00623700623700624
"Lead, urine (ng/mL)",7439-92-1,Race/eth: Non-hispanic black,0.314918379462394,0.31,0.54,1.22,2.87,554,2017-2018,0.00623700623700624
"Lead, urine (ng/mL)",7439-92-1,Race/eth: Non-hispanic white,0.270738600830644,0.27,0.5,1.23,2.27,778,2017-2018,0.00623700623700624
"Lead, urine (ng/mL)",7439-92-1,Race/eth: Other,0.246200904249618,0.27,0.46,1.17,1.86,482,2017-2018,0.00623700623700624
"Nickel, Urine (ug/L)",7440-02-0,Gender: female,1.05197588403008,1.12,2,4.15,9.97,1415,2017-2018,0.0609100680759584
"Nickel, Urine (ug/L)",7440-02-0,Gender: male,1.12198201921788,1.19,1.89,4.31,6.16,1376,2017-2018,0.0609100680759584
"Nickel, Urine (ug/L)",7440-02-0,Income: Missing,1.16005719242617,1.37,1.97,4.65,5.98,344,2017-2018,0.0609100680759584
"Nickel, Urine (ug/L)",7440-02-0,Income: PIR above 2,0.973217001570471,1.03,1.71,3.55,5.68,1180,2017-2018,0.0609100680759584
"Nickel, Urine (ug/L)",7440-02-0,Income: PIR below 2,1.27277594430651,1.28,2.22,4.64,10.35,1267,2017-2018,0.0609100680759584
"Nickel, Urine (ug/L)",7440-02-0,Race/eth: Hispanic,1.03890670294862,1.14,2.01,3.98,7.86,675,2017-2018,0.0609100680759584
"Nickel, Urine (ug/L)",7440-02-0,Race/eth: Non-hispanic black,1.32014267538179,1.37,2.22,4.64,10.05,637,2017-2018,0.0609100680759584
"Nickel, Urine (ug/L)",7440-02-0,Race/eth: Non-hispanic white,1.09046717661759,1.09,1.76,4.18,6.05,908,2017-2018,0.0609100680759584
"Nickel, Urine (ug/L)",7440-02-0,Race/eth: Other,1.10214875077504,1.21,2.16,4.12,7.08,571,2017-2018,0.0609100680759584
Urinary total Arsenic (ug/L),7440-38-2,Gender: female,5.45971700394377,5.07,10.74,43,116.02,1537,2015-2016,0.000653381247958184
Urinary total Arsenic (ug/L),7440-38-2,Gender: male,6.53886543976507,5.66,11.32,49.85,207.05,1524,2015-2016,0.000653381247958184
Urinary total Arsenic (ug/L),7440-38-2,Income: Missing,6.63822169764363,5.46,12.29,55.61,177.55,312,2015-2016,0.000653381247958184
Urinary total Arsenic (ug/L),7440-38-2,Income: PIR above 2,5.72230699971859,5.43,10.41,37.76,163.68,1457,2015-2016,0.000653381247958184
Urinary total Arsenic (ug/L),7440-38-2,Income: PIR below 2,6.0043173583146,5.31,11.1,43.43,185.5,1292,2015-2016,0.000653381247958184
Urinary total Arsenic (ug/L),7440-38-2,Race/eth: Hispanic,5.16294826179123,5.94,11.1,40.59,177.55,982,2015-2016,0.000653381247958184
Urinary total Arsenic (ug/L),7440-38-2,Race/eth: Non-hispanic black,7.89174581345198,7,15.46,62.65,200.21,671,2015-2016,0.000653381247958184
Urinary total Arsenic (ug/L),7440-38-2,Race/eth: Non-hispanic white,6.37835158624879,4.64,9.61,36.07,116.02,924,2015-2016,0.000653381247958184
Urinary total Arsenic (ug/L),7440-38-2,Race/eth: Other,9.29368347117628,8.39,19.68,73.25,175.06,484,2015-2016,0.000653381247958184
"Beryllium, urine (ng/mL)",7440-41-7,Gender: female,,,,,,1450,2009-2010,1
"Beryllium, urine (ng/mL)",7440-41-7,Gender: male,,,,,,1398,2009-2010,1
"Beryllium, urine (ng/mL)",7440-41-7,Income: Missing,,,,,,257,2009-2010,1
"Beryllium, urine (ng/mL)",7440-41-7,Income: PIR above 2,,,,,,1226,2009-2010,1
"Beryllium, urine (ng/mL)",7440-41-7,Income: PIR below 2,,,,,,1365,2009-2010,1
"Beryllium, urine (ng/mL)",7440-41-7,Race/eth: Hispanic,,,,,,899,2009-2010,1
"Beryllium, urine (ng/mL)",7440-41-7,Race/eth: Non-hispanic black,,,,,,544,2009-2010,1
"Beryllium, urine (ng/mL)",7440-41-7,Race/eth: Non-hispanic white,,,,,,1225,2009-2010,1
"Beryllium, urine (ng/mL)",7440-41-7,Race/eth: Other,,,,,,180,2009-2010,1
Urinary cadmium replicate 2 (ng/mL),7440-43-9,Gender: female,0.268446692120611,0.36,0.72,2.31,4.97,880,1988-1994,0
Urinary cadmium replicate 2 (ng/mL),7440-43-9,Gender: male,0.285992307501597,0.37,0.69,1.77,3.96,797,1988-1994,0
Urinary cadmium replicate 2 (ng/mL),7440-43-9,Income: Missing,0.280102424945958,0.37,0.68,2.01,4.44,613,1988-1994,0
Urinary cadmium replicate 2 (ng/mL),7440-43-9,Income: PIR above 2,0.270479998811001,0.34,0.7,2.2,4.59,917,1988-1994,0
Urinary cadmium replicate 2 (ng/mL),7440-43-9,Income: PIR below 2,0.311340548732866,0.43,1.04,1.95,2.7,147,1988-1994,0
Urinary cadmium replicate 2 (ng/mL),7440-43-9,Race/eth: Hispanic,0.424140257811046,0.35,0.67,1.78,4.18,434,1988-1994,0
Urinary cadmium replicate 2 (ng/mL),7440-43-9,Race/eth: Non-hispanic black,0.254872972580482,0.49,0.94,2.25,4.52,539,1988-1994,0
Urinary cadmium replicate 2 (ng/mL),7440-43-9,Race/eth: Non-hispanic white,0.249380346485241,0.35,0.65,2.01,4.05,646,1988-1994,0
Urinary cadmium replicate 2 (ng/mL),7440-43-9,Race/eth: Other,0.406693691182634,0.42,1.1,4.59,5.43,58,1988-1994,0
Urinary cadmium replicate 1 (ng/mL),7440-43-9,Gender: female,0.259775526775753,0.33,0.71,1.94,4.12,11697,1988-1994,0
Urinary cadmium replicate 1 (ng/mL),7440-43-9,Gender: male,0.251657867153304,0.33,0.69,1.83,3.34,10624,1988-1994,0
Urinary cadmium replicate 1 (ng/mL),7440-43-9,Income: Missing,0.323276709425203,0.4,0.79,2.12,3.94,2045,1988-1994,0
Urinary cadmium replicate 1 (ng/mL),7440-43-9,Income: PIR above 2,0.244101242372274,0.31,0.66,1.76,3.4,9021,1988-1994,0
Urinary cadmium replicate 1 (ng/mL),7440-43-9,Income: PIR below 2,0.265536914499144,0.34,0.74,2.07,4.09,11255,1988-1994,0
Urinary cadmium replicate 1 (ng/mL),7440-43-9,Race/eth: Hispanic,0.217265019381584,0.28,0.57,1.47,2.91,6506,1988-1994,0
Urinary cadmium replicate 1 (ng/mL),7440-43-9,Race/eth: Non-hispanic black,0.349128110595663,0.44,0.84,2.1,3.85,6669,1988-1994,0
Urinary cadmium replicate 1 (ng/mL),7440-43-9,Race/eth: Non-hispanic white,0.246040013509339,0.32,0.68,1.86,3.66,8207,1988-1994,0
Urinary cadmium replicate 1 (ng/mL),7440-43-9,Race/eth: Other,0.260157359377619,0.33,0.76,2.22,4.8,939,1988-1994,0
Blood cadmium (ug/L),7440-43-9,Gender: female,0.259266253177327,0.26,0.46,1.46,2.96,3847,2017-2018,0.185811260481832
Blood cadmium (ug/L),7440-43-9,Gender: male,0.199115472877796,0.19,0.33,1.14,2.03,3666,2017-2018,0.185811260481832
Blood cadmium (ug/L),7440-43-9,Income: Missing,0.237390600309653,0.24,0.42,1.21,2.85,918,2017-2018,0.185811260481832
Blood cadmium (ug/L),7440-43-9,Income: PIR above 2,0.23945441482303,0.22,0.49,1.55,3.01,3384,2017-2018,0.185811260481832
Blood cadmium (ug/L),7440-43-9,Income: PIR below 2,0.219969057240493,0.22,0.36,1.04,2.22,3211,2017-2018,0.185811260481832
Blood cadmium (ug/L),7440-43-9,Race/eth: Hispanic,0.274357136845007,0.18,0.31,0.8,1.68,1816,2017-2018,0.185811260481832
Blood cadmium (ug/L),7440-43-9,Race/eth: Non-hispanic black,0.234570574010072,0.24,0.47,1.34,2.83,1708,2017-2018,0.185811260481832
Blood cadmium (ug/L),7440-43-9,Race/eth: Non-hispanic white,0.175370595854437,0.23,0.4,1.34,2.77,2536,2017-2018,0.185811260481832
Blood cadmium (ug/L),7440-43-9,Race/eth: Other,0.250254210891087,0.28,0.51,1.43,2.83,1453,2017-2018,0.185811260481832
Urinary cadmium (ng/mL),7440-43-9,Gender: female,0.135238009859418,0.156,0.316,0.919,1.683,1427,2017-2018,0.213675213675214
Urinary cadmium (ng/mL),7440-43-9,Gender: male,0.116655650723133,0.125,0.241,0.66,1.485,1381,2017-2018,0.213675213675214
Urinary cadmium (ng/mL),7440-43-9,Income: Missing,0.149787041613201,0.154,0.312,1.029,2.108,347,2017-2018,0.213675213675214
Urinary cadmium (ng/mL),7440-43-9,Income: PIR above 2,0.117750787215513,0.129,0.268,0.694,1.431,1188,2017-2018,0.213675213675214
Urinary cadmium (ng/mL),7440-43-9,Income: PIR below 2,0.132517997452786,0.151,0.292,0.918,1.73,1273,2017-2018,0.213675213675214
Urinary cadmium (ng/mL),7440-43-9,Race/eth: Hispanic,0.12502922610881,0.109,0.206,0.653,1.261,676,2017-2018,0.213675213675214
Urinary cadmium (ng/mL),7440-43-9,Race/eth: Non-hispanic black,0.168850938275631,0.177,0.393,1.02,1.802,639,2017-2018,0.213675213675214
Urinary cadmium (ng/mL),7440-43-9,Race/eth: Non-hispanic white,0.143140103399956,0.138,0.274,0.805,1.485,918,2017-2018,0.213675213675214
Urinary cadmium (ng/mL),7440-43-9,Race/eth: Other,0.0976006487746254,0.144,0.382,0.983,2.312,575,2017-2018,0.213675213675214
Cobalt (ug/L),7440-48-4,Gender: female,0.161016442499299,0.17,0.22,0.47,0.88,1803,2017-2018,0.00852272727272727
Cobalt (ug/L),7440-48-4,Gender: male,0.184064096312354,0.15,0.18,0.38,1.09,1717,2017-2018,0.00852272727272727
Cobalt (ug/L),7440-48-4,Income: Missing,0.180589354667804,0.17,0.23,0.48,1.23,464,2017-2018,0.00852272727272727
Cobalt (ug/L),7440-48-4,Income: PIR above 2,0.171690983578762,0.15,0.19,0.43,0.81,1664,2017-2018,0.00852272727272727
Cobalt (ug/L),7440-48-4,Income: PIR below 2,0.172427155841982,0.16,0.2,0.44,0.9,1392,2017-2018,0.00852272727272727
Cobalt (ug/L),7440-48-4,Race/eth: Hispanic,0.173289585864515,0.15,0.18,0.41,0.79,775,2017-2018,0.00852272727272727
Cobalt (ug/L),7440-48-4,Race/eth: Non-hispanic black,0.168327109347458,0.15,0.19,0.37,0.64,816,2017-2018,0.00852272727272727
Cobalt (ug/L),7440-48-4,Race/eth: Non-hispanic white,0.161946965494912,0.16,0.2,0.45,1.08,1272,2017-2018,0.00852272727272727
Cobalt (ug/L),7440-48-4,Race/eth: Other,0.175356201285453,0.16,0.2,0.37,0.78,657,2017-2018,0.00852272727272727
"Cobalt, urine (ng/mL)",7440-48-4,Gender: female,0.428050987822656,0.446,0.76,1.613,3.269,1427,2017-2018,0.00106837606837607
"Cobalt, urine (ng/mL)",7440-48-4,Gender: male,0.418675099539132,0.427,0.679,1.471,5.644,1381,2017-2018,0.00106837606837607
"Cobalt, urine (ng/mL)",7440-48-4,Income: Missing,0.499028891658401,0.478,0.844,1.765,3.778,347,2017-2018,0.00106837606837607
"Cobalt, urine (ng/mL)",7440-48-4,Income: PIR above 2,0.387212328431203,0.399,0.646,1.471,4.795,1188,2017-2018,0.00106837606837607
"Cobalt, urine (ng/mL)",7440-48-4,Income: PIR below 2,0.465228924668428,0.492,0.78,1.634,3.43,1273,2017-2018,0.00106837606837607
"Cobalt, urine (ng/mL)",7440-48-4,Race/eth: Hispanic,0.411045020598771,0.451,0.742,1.413,3.43,676,2017-2018,0.00106837606837607
"Cobalt, urine (ng/mL)",7440-48-4,Race/eth: Non-hispanic black,0.470118907946054,0.476,0.718,1.863,2.494,639,2017-2018,0.00106837606837607
"Cobalt, urine (ng/mL)",7440-48-4,Race/eth: Non-hispanic white,0.417219958939337,0.428,0.702,1.572,5.644,918,2017-2018,0.00106837606837607
"Cobalt, urine (ng/mL)",7440-48-4,Race/eth: Other,0.440426372873554,0.44,0.735,1.641,2.808,575,2017-2018,0.00106837606837607
Acrylonitrile metabolite: N-Acetyl-S-(1-cyano-2-hydroxyethyl)-L-cysteine (CYHA) (ng/mL),107-13-1,Gender: female,,,,33.1,114,1516,2015-2016,0.854063018242123
Acrylonitrile metabolite: N-Acetyl-S-(1-cyano-2-hydroxyethyl)-L-cysteine (CYHA) (ng/mL),107-13-1,Gender: male,,,,42.8,123,1499,2015-2016,0.854063018242123
Acrylonitrile metabolite: N-Acetyl-S-(1-cyano-2-hydroxyethyl)-L-cysteine (CYHA) (ng/mL),107-13-1,Income: Missing,,,,61.4,166,311,2015-2016,0.854063018242123
Acrylonitrile metabolite: N-Acetyl-S-(1-cyano-2-hydroxyethyl)-L-cysteine (CYHA) (ng/mL),107-13-1,Income: PIR above 2,,,,56.1,136,1433,2015-2016,0.854063018242123
Acrylonitrile metabolite: N-Acetyl-S-(1-cyano-2-hydroxyethyl)-L-cysteine (CYHA) (ng/mL),107-13-1,Income: PIR below 2,,,,26.7,68.8,1271,2015-2016,0.854063018242123
Acrylonitrile metabolite: N-Acetyl-S-(1-cyano-2-hydroxyethyl)-L-cysteine (CYHA) (ng/mL),107-13-1,Race/eth: Hispanic,,,,21.5,98,970,2015-2016,0.854063018242123
Acrylonitrile metabolite: N-Acetyl-S-(1-cyano-2-hydroxyethyl)-L-cysteine (CYHA) (ng/mL),107-13-1,Race/eth: Non-hispanic black,,,4.63,63.3,143,656,2015-2016,0.854063018242123
Acrylonitrile metabolite: N-Acetyl-S-(1-cyano-2-hydroxyethyl)-L-cysteine (CYHA) (ng/mL),107-13-1,Race/eth: Non-hispanic white,,,,37.2,118,912,2015-2016,0.854063018242123
Acrylonitrile metabolite: N-Acetyl-S-(1-cyano-2-hydroxyethyl)-L-cysteine (CYHA) (ng/mL),107-13-1,Race/eth: Other,,,,24,83.6,477,2015-2016,0.854063018242123
Acrylonitrile metabolite: N-acetyl-S-(2-cyanoethyl)-L-cysteine (ng/mL),107-13-1,Gender: female,1.77844094213706,1.11,2.92,145,390,1516,2015-2016,0.214262023217247
Acrylonitrile metabolite: N-acetyl-S-(2-cyanoethyl)-L-cysteine (ng/mL),107-13-1,Gender: male,3.04961516446451,1.62,6.58,258,593,1499,2015-2016,0.214262023217247
Acrylonitrile metabolite: N-acetyl-S-(2-cyanoethyl)-L-cysteine (ng/mL),107-13-1,Income: Missing,2.5449070672417,1.41,3.73,484,611,311,2015-2016,0.214262023217247
Acrylonitrile metabolite: N-acetyl-S-(2-cyanoethyl)-L-cysteine (ng/mL),107-13-1,Income: PIR above 2,3.18601196331897,1.51,17.3,258,654,1433,2015-2016,0.214262023217247
Acrylonitrile metabolite: N-acetyl-S-(2-cyanoethyl)-L-cysteine (ng/mL),107-13-1,Income: PIR below 2,1.90908264375024,1.27,3.2,158,359,1271,2015-2016,0.214262023217247
Acrylonitrile metabolite: N-acetyl-S-(2-cyanoethyl)-L-cysteine (ng/mL),107-13-1,Race/eth: Hispanic,2.294202153164,1.18,2.36,118,392,970,2015-2016,0.214262023217247
Acrylonitrile metabolite: N-acetyl-S-(2-cyanoethyl)-L-cysteine (ng/mL),107-13-1,Race/eth: Non-hispanic black,5.53473444328169,2.41,34.1,376,757,656,2015-2016,0.214262023217247
Acrylonitrile metabolite: N-acetyl-S-(2-cyanoethyl)-L-cysteine (ng/mL),107-13-1,Race/eth: Non-hispanic white,1.62900896454982,1.3,4.28,182,545,912,2015-2016,0.214262023217247
Acrylonitrile metabolite: N-acetyl-S-(2-cyanoethyl)-L-cysteine (ng/mL),107-13-1,Race/eth: Other,1.59452307134258,1.19,2.28,131,484,477,2015-2016,0.214262023217247
Blood Chloroethane (ng/mL),75-00-3,Gender: female,,,,,,1425,2017-2018,0.998921639108555
Blood Chloroethane (ng/mL),75-00-3,Gender: male,,,,,,1357,2017-2018,0.998921639108555
Blood Chloroethane (ng/mL),75-00-3,Income: Missing,,,,,,361,2017-2018,0.998921639108555
Blood Chloroethane (ng/mL),75-00-3,Income: PIR above 2,,,,,,1247,2017-2018,0.998921639108555
Blood Chloroethane (ng/mL),75-00-3,Income: PIR below 2,,,,,,1174,2017-2018,0.998921639108555
Blood Chloroethane (ng/mL),75-00-3,Race/eth: Hispanic,,,,,,654,2017-2018,0.998921639108555
Blood Chloroethane (ng/mL),75-00-3,Race/eth: Non-hispanic black,,,,,,616,2017-2018,0.998921639108555
Blood Chloroethane (ng/mL),75-00-3,Race/eth: Non-hispanic white,,,,,,961,2017-2018,0.998921639108555
Blood Chloroethane (ng/mL),75-00-3,Race/eth: Other,,,,,,551,2017-2018,0.998921639108555
Blood Methylene Chloride (ng/mL),75-09-2,Gender: female,,,,,,1472,2017-2018,0.997905759162304
Blood Methylene Chloride (ng/mL),75-09-2,Gender: male,,,,,,1393,2017-2018,0.997905759162304
Blood Methylene Chloride (ng/mL),75-09-2,Income: Missing,,,,,,1197,2017-2018,0.997905759162304
Blood Methylene Chloride (ng/mL),75-09-2,Income: PIR above 2,,,,,,378,2017-2018,0.997905759162304
Blood Methylene Chloride (ng/mL),75-09-2,Income: PIR below 2,,,,,,1290,2017-2018,0.997905759162304
Blood Methylene Chloride (ng/mL),75-09-2,Race/eth: Hispanic,,,,,,682,2017-2018,0.997905759162304
Blood Methylene Chloride (ng/mL),75-09-2,Race/eth: Non-hispanic black,,,,,,637,2017-2018,0.997905759162304
Blood Methylene Chloride (ng/mL),75-09-2,Race/eth: Non-hispanic white,,,,,,976,2017-2018,0.997905759162304
Blood Methylene Chloride (ng/mL),75-09-2,Race/eth: Other,,,,,,570,2017-2018,0.997905759162304
Ethylene Oxide (pmol/g Hb),75-21-8,Gender: female,21.6706822289437,17.89,27.16,212.56,416.14,1194,2015-2016,0.147789473684211
Ethylene Oxide (pmol/g Hb),75-21-8,Gender: male,25.8044784209204,19.11,35.84,247.99,425.94,1181,2015-2016,0.147789473684211
Ethylene Oxide (pmol/g Hb),75-21-8,Income: Missing,27.902151859854,20.6,31.35,212.56,290.3,240,2015-2016,0.147789473684211
Ethylene Oxide (pmol/g Hb),75-21-8,Income: PIR above 2,29.0777893415364,21.08,49.42,263.55,548.64,1079,2015-2016,0.147789473684211
Ethylene Oxide (pmol/g Hb),75-21-8,Income: PIR below 2,20.6488217182824,17.28,26.13,222.14,404.84,1056,2015-2016,0.147789473684211
Ethylene Oxide (pmol/g Hb),75-21-8,Race/eth: Hispanic,22.3613381218096,18.97,26.4,128.56,332.82,750,2015-2016,0.147789473684211
Ethylene Oxide (pmol/g Hb),75-21-8,Race/eth: Non-hispanic black,34.5756161621824,24.28,65.61,293.27,484.13,493,2015-2016,0.147789473684211
Ethylene Oxide (pmol/g Hb),75-21-8,Race/eth: Non-hispanic white,21.7127078280689,17.35,27.64,258.36,416.14,756,2015-2016,0.147789473684211
Ethylene Oxide (pmol/g Hb),75-21-8,Race/eth: Other,24.672003513341,21.89,31.9,159.07,624.88,376,2015-2016,0.147789473684211
Blood Bromoform (pg/mL),75-25-2,Gender: female,,,,10,24,1465,2017-2018,0.920546027301365
Blood Bromoform (pg/mL),75-25-2,Gender: male,,,,11,27,1392,2017-2018,0.920546027301365
Blood Bromoform (pg/mL),75-25-2,Income: Missing,,,,13,27,1192,2017-2018,0.920546027301365
Blood Bromoform (pg/mL),75-25-2,Income: PIR above 2,,,,11,27,377,2017-2018,0.920546027301365
Blood Bromoform (pg/mL),75-25-2,Income: PIR below 2,,,,10,19,1288,2017-2018,0.920546027301365
Blood Bromoform (pg/mL),75-25-2,Race/eth: Hispanic,,,,12,21,677,2017-2018,0.920546027301365
Blood Bromoform (pg/mL),75-25-2,Race/eth: Non-hispanic black,,,,8,27,637,2017-2018,0.920546027301365
Blood Bromoform (pg/mL),75-25-2,Race/eth: Non-hispanic white,,,,10,27,976,2017-2018,0.920546027301365
Blood Bromoform (pg/mL),75-25-2,Race/eth: Other,,,,10,21,567,2017-2018,0.920546027301365
Blood Bromodichloromethane (pg/mL),75-27-4,Gender: female,,,,11,18,1472,2017-2018,0.831005586592179
Blood Bromodichloromethane (pg/mL),75-27-4,Gender: male,,,,11,21,1392,2017-2018,0.831005586592179
Blood Bromodichloromethane (pg/mL),75-27-4,Income: Missing,,,,11,21,1197,2017-2018,0.831005586592179
Blood Bromodichloromethane (pg/mL),75-27-4,Income: PIR above 2,,,,12,25,377,2017-2018,0.831005586592179
Blood Bromodichloromethane (pg/mL),75-27-4,Income: PIR below 2,,,,11,18,1290,2017-2018,0.831005586592179
Blood Bromodichloromethane (pg/mL),75-27-4,Race/eth: Hispanic,,,,11,18,682,2017-2018,0.831005586592179
Blood Bromodichloromethane (pg/mL),75-27-4,Race/eth: Non-hispanic black,,,,11,20,637,2017-2018,0.831005586592179
Blood Bromodichloromethane (pg/mL),75-27-4,Race/eth: Non-hispanic white,,,,10,21,976,2017-2018,0.831005586592179
Blood Bromodichloromethane (pg/mL),75-27-4,Race/eth: Other,,,,12,20,569,2017-2018,0.831005586592179
"Blood 1,1-Dichloroethane (ng/mL)",75-34-3,Gender: female,,,,,,1369,2011-2012,1
"Blood 1,1-Dichloroethane (ng/mL)",75-34-3,Gender: male,,,,,,1367,2011-2012,1
"Blood 1,1-Dichloroethane (ng/mL)",75-34-3,Income: Missing,,,,,,235,2011-2012,1
"Blood 1,1-Dichloroethane (ng/mL)",75-34-3,Income: PIR above 2,,,,,,1205,2011-2012,1
"Blood 1,1-Dichloroethane (ng/mL)",75-34-3,Income: PIR below 2,,,,,,1296,2011-2012,1
"Blood 1,1-Dichloroethane (ng/mL)",75-34-3,Race/eth: Hispanic,,,,,,597,2011-2012,1
"Blood 1,1-Dichloroethane (ng/mL)",75-34-3,Race/eth: Non-hispanic black,,,,,,734,2011-2012,1
"Blood 1,1-Dichloroethane (ng/mL)",75-34-3,Race/eth: Non-hispanic white,,,,,,928,2011-2012,1
"Blood 1,1-Dichloroethane (ng/mL)",75-34-3,Race/eth: Other,,,,,,477,2011-2012,1
"Blood 1,1-Dichloroethene (ng/mL)",75-35-4,Gender: female,,,,,,1398,2011-2012,1
"Blood 1,1-Dichloroethene (ng/mL)",75-35-4,Gender: male,,,,,,1406,2011-2012,1
"Blood 1,1-Dichloroethene (ng/mL)",75-35-4,Income: Missing,,,,,,240,2011-2012,1
"Blood 1,1-Dichloroethene (ng/mL)",75-35-4,Income: PIR above 2,,,,,,1246,2011-2012,1
"Blood 1,1-Dichloroethene (ng/mL)",75-35-4,Income: PIR below 2,,,,,,1318,2011-2012,1
"Blood 1,1-Dichloroethene (ng/mL)",75-35-4,Race/eth: Hispanic,,,,,,596,2011-2012,1
"Blood 1,1-Dichloroethene (ng/mL)",75-35-4,Race/eth: Non-hispanic black,,,,,,739,2011-2012,1
"Blood 1,1-Dichloroethene (ng/mL)",75-35-4,Race/eth: Non-hispanic white,,,,,,969,2011-2012,1
"Blood 1,1-Dichloroethene (ng/mL)",75-35-4,Race/eth: Other,,,,,,500,2011-2012,1
Blood Nitromethane (pg/mL),75-52-5,Gender: female,690.913569540869,663,866,1430,2090,1147,2011-2012,0
Blood Nitromethane (pg/mL),75-52-5,Gender: male,668.269564102957,641,821,1340,1790,1137,2011-2012,0
Blood Nitromethane (pg/mL),75-52-5,Income: Missing,710.880552824602,641,905,1580,2100,205,2011-2012,0
Blood Nitromethane (pg/mL),75-52-5,Income: PIR above 2,680.29033250157,663,833,1330,1770,989,2011-2012,0
Blood Nitromethane (pg/mL),75-52-5,Income: PIR below 2,673.755166501429,639,848,1450,2280,1090,2011-2012,0
Blood Nitromethane (pg/mL),75-52-5,Race/eth: Hispanic,655.453758711692,694,851,1330,1740,483,2011-2012,0
Blood Nitromethane (pg/mL),75-52-5,Race/eth: Non-hispanic black,750.707735337015,716,933,1730,2500,629,2011-2012,0
Blood Nitromethane (pg/mL),75-52-5,Race/eth: Non-hispanic white,778.239685177886,635,799,1320,1780,806,2011-2012,0
Blood Nitromethane (pg/mL),75-52-5,Race/eth: Other,691.730363252013,768,980,1490,2190,366,2011-2012,0
Urinary Dimethylarsonic acid (ug/L),75-60-5,Gender: female,2.60509323646831,2.66,4.86,11.99,28.84,1432,2017-2018,0.283185840707965
Urinary Dimethylarsonic acid (ug/L),75-60-5,Gender: male,2.88448443791901,3.17,5.12,10.25,19.04,1393,2017-2018,0.283185840707965
Urinary Dimethylarsonic acid (ug/L),75-60-5,Income: Missing,3.55131403516078,3.57,6.46,17.89,43.94,351,2017-2018,0.283185840707965
Urinary Dimethylarsonic acid (ug/L),75-60-5,Income: PIR above 2,2.58186314723895,2.74,4.63,10.25,25.76,1194,2017-2018,0.283185840707965
Urinary Dimethylarsonic acid (ug/L),75-60-5,Income: PIR below 2,2.7714354076639,2.94,5.09,10.79,19.74,1280,2017-2018,0.283185840707965
Urinary Dimethylarsonic acid (ug/L),75-60-5,Race/eth: Hispanic,2.43487719324866,3.57,5.85,13.09,23.24,676,2017-2018,0.283185840707965
Urinary Dimethylarsonic acid (ug/L),75-60-5,Race/eth: Non-hispanic black,3.00904677998776,3.14,5.34,12.65,28.84,644,2017-2018,0.283185840707965
Urinary Dimethylarsonic acid (ug/L),75-60-5,Race/eth: Non-hispanic white,3.46939502750395,2.61,4.39,8.92,17.89,926,2017-2018,0.283185840707965
Urinary Dimethylarsonic acid (ug/L),75-60-5,Race/eth: Other,3.28073794256821,3.53,6.84,18.8,59.49,579,2017-2018,0.283185840707965
"2-amino-3-methyl-3H-imidazo[4,5-f] quinolone (pg/mL)",76180-96-6,Gender: female,,,,,0.77,1285,2013-2014,0.979393468118196
"2-amino-3-methyl-3H-imidazo[4,5-f] quinolone (pg/mL)",76180-96-6,Gender: male,,,,,0.77,1287,2013-2014,0.979393468118196
"2-amino-3-methyl-3H-imidazo[4,5-f] quinolone (pg/mL)",76180-96-6,Income: Missing,,,,,1.18,180,2013-2014,0.979393468118196
"2-amino-3-methyl-3H-imidazo[4,5-f] quinolone (pg/mL)",76180-96-6,Income: PIR above 2,,,,,0.67,1246,2013-2014,0.979393468118196
"2-amino-3-methyl-3H-imidazo[4,5-f] quinolone (pg/mL)",76180-96-6,Income: PIR below 2,,,,,0.65,1146,2013-2014,0.979393468118196
"2-amino-3-methyl-3H-imidazo[4,5-f] quinolone (pg/mL)",76180-96-6,Race/eth: Hispanic,,,,,0.69,683,2013-2014,0.979393468118196
"2-amino-3-methyl-3H-imidazo[4,5-f] quinolone (pg/mL)",76180-96-6,Race/eth: Non-hispanic black,,,,,1.16,555,2013-2014,0.979393468118196
"2-amino-3-methyl-3H-imidazo[4,5-f] quinolone (pg/mL)",76180-96-6,Race/eth: Non-hispanic white,,,,,0.77,946,2013-2014,0.979393468118196
"2-amino-3-methyl-3H-imidazo[4,5-f] quinolone (pg/mL)",76180-96-6,Race/eth: Other,,,,,0.65,388,2013-2014,0.979393468118196
"Blood 1,2-Dichloropropane (ng/mL)",78-87-5,Gender: female,,,,,,1369,2011-2012,1
"Blood 1,2-Dichloropropane (ng/mL)",78-87-5,Gender: male,,,,,,1371,2011-2012,1
"Blood 1,2-Dichloropropane (ng/mL)",78-87-5,Income: Missing,,,,,,241,2011-2012,1
"Blood 1,2-Dichloropropane (ng/mL)",78-87-5,Income: PIR above 2,,,,,,1206,2011-2012,1
"Blood 1,2-Dichloropropane (ng/mL)",78-87-5,Income: PIR below 2,,,,,,1293,2011-2012,1
"Blood 1,2-Dichloropropane (ng/mL)",78-87-5,Race/eth: Hispanic,,,,,,589,2011-2012,1
"Blood 1,2-Dichloropropane (ng/mL)",78-87-5,Race/eth: Non-hispanic black,,,,,,718,2011-2012,1
"Blood 1,2-Dichloropropane (ng/mL)",78-87-5,Race/eth: Non-hispanic white,,,,,,937,2011-2012,1
"Blood 1,2-Dichloropropane (ng/mL)",78-87-5,Race/eth: Other,,,,,,496,2011-2012,1
"Blood 1,1,2-Trichloroethane (ng/mL)",79-00-5,Gender: female,,,,,,1391,2011-2012,1
"Blood 1,1,2-Trichloroethane (ng/mL)",79-00-5,Gender: male,,,,,,1392,2011-2012,1
"Blood 1,1,2-Trichloroethane (ng/mL)",79-00-5,Income: Missing,,,,,,237,2011-2012,1
"Blood 1,1,2-Trichloroethane (ng/mL)",79-00-5,Income: PIR above 2,,,,,,1235,2011-2012,1
"Blood 1,1,2-Trichloroethane (ng/mL)",79-00-5,Income: PIR below 2,,,,,,1311,2011-2012,1
"Blood 1,1,2-Trichloroethane (ng/mL)",79-00-5,Race/eth: Hispanic,,,,,,588,2011-2012,1
"Blood 1,1,2-Trichloroethane (ng/mL)",79-00-5,Race/eth: Non-hispanic black,,,,,,738,2011-2012,1
"Blood 1,1,2-Trichloroethane (ng/mL)",79-00-5,Race/eth: Non-hispanic white,,,,,,971,2011-2012,1
"Blood 1,1,2-Trichloroethane (ng/mL)",79-00-5,Race/eth: Other,,,,,,486,2011-2012,1
Blood Trichloroethene (ng/mL),79-01-6,Gender: female,,,,,,1473,2017-2018,0.993719469644103
Blood Trichloroethene (ng/mL),79-01-6,Gender: male,,,,,,1393,2017-2018,0.993719469644103
Blood Trichloroethene (ng/mL),79-01-6,Income: Missing,,,,,,1197,2017-2018,0.993719469644103
Blood Trichloroethene (ng/mL),79-01-6,Income: PIR above 2,,,,,,378,2017-2018,0.993719469644103
Blood Trichloroethene (ng/mL),79-01-6,Income: PIR below 2,,,,,,1291,2017-2018,0.993719469644103
Blood Trichloroethene (ng/mL),79-01-6,Race/eth: Hispanic,,,,,,682,2017-2018,0.993719469644103
Blood Trichloroethene (ng/mL),79-01-6,Race/eth: Non-hispanic black,,,,,,637,2017-2018,0.993719469644103
Blood Trichloroethene (ng/mL),79-01-6,Race/eth: Non-hispanic white,,,,,,977,2017-2018,0.993719469644103
Blood Trichloroethene (ng/mL),79-01-6,Race/eth: Other,,,,,0.012,570,2017-2018,0.993719469644103
Acrylamide (pmoL/g Hb),79-06-1,Gender: female,44.9396577451256,40.6,56,123,241,1226,2015-2016,0
Acrylamide (pmoL/g Hb),79-06-1,Gender: male,50.8785223073896,44.5,65.6,185,368,1187,2015-2016,0
Acrylamide (pmoL/g Hb),79-06-1,Income: Missing,48.9118846037244,40.7,64.4,154,257,239,2015-2016,0
Acrylamide (pmoL/g Hb),79-06-1,Income: PIR above 2,50.402135942217,43.1,65.8,186,344,1115,2015-2016,0
Acrylamide (pmoL/g Hb),79-06-1,Income: PIR below 2,46.1568644910038,42,56.3,129,276,1059,2015-2016,0
Acrylamide (pmoL/g Hb),79-06-1,Race/eth: Hispanic,47.9993563547739,41.3,53.5,125,284,800,2015-2016,0
Acrylamide (pmoL/g Hb),79-06-1,Race/eth: Non-hispanic black,53.9611753804726,47.9,74.8,246,371,478,2015-2016,0
Acrylamide (pmoL/g Hb),79-06-1,Race/eth: Non-hispanic white,45.2203878239858,41.9,60.3,144,261,757,2015-2016,0
Acrylamide (pmoL/g Hb),79-06-1,Race/eth: Other,44.0889931241679,42,61.1,108,260,378,2015-2016,0
"Blood 1,1,2,2-Tetrachloroethane (ng/mL)",79-34-5,Gender: female,,,,,,1335,2011-2012,0.998881014546811
"Blood 1,1,2,2-Tetrachloroethane (ng/mL)",79-34-5,Gender: male,,,,,,1346,2011-2012,0.998881014546811
"Blood 1,1,2,2-Tetrachloroethane (ng/mL)",79-34-5,Income: Missing,,,,,,232,2011-2012,0.998881014546811
"Blood 1,1,2,2-Tetrachloroethane (ng/mL)",79-34-5,Income: PIR above 2,,,,,,1203,2011-2012,0.998881014546811
"Blood 1,1,2,2-Tetrachloroethane (ng/mL)",79-34-5,Income: PIR below 2,,,,,,1246,2011-2012,0.998881014546811
"Blood 1,1,2,2-Tetrachloroethane (ng/mL)",79-34-5,Race/eth: Hispanic,,,,,,569,2011-2012,0.998881014546811
"Blood 1,1,2,2-Tetrachloroethane (ng/mL)",79-34-5,Race/eth: Non-hispanic black,,,,,,720,2011-2012,0.998881014546811
"Blood 1,1,2,2-Tetrachloroethane (ng/mL)",79-34-5,Race/eth: Non-hispanic white,,,,,,913,2011-2012,0.998881014546811
"Blood 1,1,2,2-Tetrachloroethane (ng/mL)",79-34-5,Race/eth: Other,,,,,,479,2011-2012,0.998881014546811
Acrylamide metabolite: N-acetyl-S-(2-carbamoylethyl)-L-cysteine (ng/mL),79-06-1,Gender: female,43.1591440144751,42.5,85.4,196,432,1516,2015-2016,0.00099502487562189
Acrylamide metabolite: N-acetyl-S-(2-carbamoylethyl)-L-cysteine (ng/mL),79-06-1,Gender: male,59.0414107089901,60.9,113,286,594,1499,2015-2016,0.00099502487562189
Acrylamide metabolite: N-acetyl-S-(2-carbamoylethyl)-L-cysteine (ng/mL),79-06-1,Income: Missing,53.8320510961248,51.5,97.9,262,425,311,2015-2016,0.00099502487562189
Acrylamide metabolite: N-acetyl-S-(2-carbamoylethyl)-L-cysteine (ng/mL),79-06-1,Income: PIR above 2,53.4071108206837,55.2,105,293,636,1433,2015-2016,0.00099502487562189
Acrylamide metabolite: N-acetyl-S-(2-carbamoylethyl)-L-cysteine (ng/mL),79-06-1,Income: PIR below 2,48.153545198309,47.9,90.5,211,400,1271,2015-2016,0.00099502487562189
Acrylamide metabolite: N-acetyl-S-(2-carbamoylethyl)-L-cysteine (ng/mL),79-06-1,Race/eth: Hispanic,48.551075358107,50.1,90.5,228,471,970,2015-2016,0.00099502487562189
Acrylamide metabolite: N-acetyl-S-(2-carbamoylethyl)-L-cysteine (ng/mL),79-06-1,Race/eth: Non-hispanic black,73.0828529134508,73.3,139,356,802,656,2015-2016,0.00099502487562189
Acrylamide metabolite: N-acetyl-S-(2-carbamoylethyl)-L-cysteine (ng/mL),79-06-1,Race/eth: Non-hispanic white,49.0433221106025,47.4,93.2,220,395,912,2015-2016,0.00099502487562189
Acrylamide metabolite: N-acetyl-S-(2-carbamoylethyl)-L-cysteine (ng/mL),79-06-1,Race/eth: Other,41.8104848939225,36.6,86.4,233,795,477,2015-2016,0.00099502487562189
"2,6-Dimethylaniline, urine (pg/mL)",87-62-7,Gender: female,26.9757922769575,21.4,50.4,433,15700,1201,2013-2014,0.357894736842105
"2,6-Dimethylaniline, urine (pg/mL)",87-62-7,Gender: male,28.5508828776106,25.2,55.4,340,5580,1174,2013-2014,0.357894736842105
"2,6-Dimethylaniline, urine (pg/mL)",87-62-7,Income: Missing,25.3725189820313,17.2,49,248,229000,165,2013-2014,0.357894736842105
"2,6-Dimethylaniline, urine (pg/mL)",87-62-7,Income: PIR above 2,29.0508152749611,24.8,56.5,386,6700,1149,2013-2014,0.357894736842105
"2,6-Dimethylaniline, urine (pg/mL)",87-62-7,Income: PIR below 2,27.1715647265349,21.9,50.7,395,11000,1061,2013-2014,0.357894736842105
"2,6-Dimethylaniline, urine (pg/mL)",87-62-7,Race/eth: Hispanic,34.9003994872129,23.2,51.3,288,6410,640,2013-2014,0.357894736842105
"2,6-Dimethylaniline, urine (pg/mL)",87-62-7,Race/eth: Non-hispanic black,21.0711904227352,31.5,63.1,340,20100,502,2013-2014,0.357894736842105
"2,6-Dimethylaniline, urine (pg/mL)",87-62-7,Race/eth: Non-hispanic white,26.5622933971145,22.1,54.8,448,11400,871,2013-2014,0.357894736842105
"2,6-Dimethylaniline, urine (pg/mL)",87-62-7,Race/eth: Other,27.9583509821739,18.2,36.9,260,6070,362,2013-2014,0.357894736842105
Pentachlorophenol (ug/L),87-86-5,Gender: female,,,0.88,3.2,6.68,1207,2003-2004,0.659728122344945
Pentachlorophenol (ug/L),87-86-5,Gender: male,,,1.32,4.58,16.02,1147,2003-2004,0.659728122344945
Pentachlorophenol (ug/L),87-86-5,Income: Missing,,,1.08,5.59,9.71,118,2003-2004,0.659728122344945
Pentachlorophenol (ug/L),87-86-5,Income: PIR above 2,,,1.33,3.41,6.96,1137,2003-2004,0.659728122344945
Pentachlorophenol (ug/L),87-86-5,Income: PIR below 2,,,1.02,3.69,11.32,1099,2003-2004,0.659728122344945
Pentachlorophenol (ug/L),87-86-5,Race/eth: Hispanic,,,0.9,2.92,4.58,630,2003-2004,0.659728122344945
Pentachlorophenol (ug/L),87-86-5,Race/eth: Non-hispanic black,,,1.46,4.06,6.96,593,2003-2004,0.659728122344945
Pentachlorophenol (ug/L),87-86-5,Race/eth: Non-hispanic white,,,1.18,3.69,11.48,1024,2003-2004,0.659728122344945
Pentachlorophenol (ug/L),87-86-5,Race/eth: Other,,,,2.79,6.13,107,2003-2004,0.659728122344945
"2,4,6-trichlorophenol (ug/L)",88-06-2,Gender: female,,,0.5,1.1,3.3,1350,2009-2010,0.720261913423063
"2,4,6-trichlorophenol (ug/L)",88-06-2,Gender: male,,,,1.1,2.9,1399,2009-2010,0.720261913423063
"2,4,6-trichlorophenol (ug/L)",88-06-2,Income: Missing,,,0.6,1.2,2.2,258,2009-2010,0.720261913423063
"2,4,6-trichlorophenol (ug/L)",88-06-2,Income: PIR above 2,,,0.6,1.3,3.3,1371,2009-2010,0.720261913423063
"2,4,6-trichlorophenol (ug/L)",88-06-2,Income: PIR below 2,,,,1,3.9,1120,2009-2010,0.720261913423063
"2,4,6-trichlorophenol (ug/L)",88-06-2,Race/eth: Hispanic,,,0.5,1.3,2.5,859,2009-2010,0.720261913423063
"2,4,6-trichlorophenol (ug/L)",88-06-2,Race/eth: Non-hispanic black,,,0.7,1.5,3.3,516,2009-2010,0.720261913423063
"2,4,6-trichlorophenol (ug/L)",88-06-2,Race/eth: Non-hispanic white,,,,1,4.8,1206,2009-2010,0.720261913423063
"2,4,6-trichlorophenol (ug/L)",88-06-2,Race/eth: Other,,,,1,1.6,168,2009-2010,0.720261913423063
"o-Anisidine, urine (pg/mL)",90-04-0,Gender: female,42.9633165058717,43,83.1,204,427,1159,2013-2014,0.0214408233276158
"o-Anisidine, urine (pg/mL)",90-04-0,Gender: male,54.0894362551113,52.1,93.7,231,912,1173,2013-2014,0.0214408233276158
"o-Anisidine, urine (pg/mL)",90-04-0,Income: Missing,42.3873914358869,45.4,83.2,161,231,159,2013-2014,0.0214408233276158
"o-Anisidine, urine (pg/mL)",90-04-0,Income: PIR above 2,47.3889001644621,48.9,88.1,200,481,1133,2013-2014,0.0214408233276158
"o-Anisidine, urine (pg/mL)",90-04-0,Income: PIR below 2,49.3682387392616,47.9,88.1,233,568,1040,2013-2014,0.0214408233276158
"o-Anisidine, urine (pg/mL)",90-04-0,Race/eth: Hispanic,48.5672106743093,42.5,76.9,189,481,609,2013-2014,0.0214408233276158
"o-Anisidine, urine (pg/mL)",90-04-0,Race/eth: Non-hispanic black,39.819293201812,49.9,86.2,178,312,504,2013-2014,0.0214408233276158
"o-Anisidine, urine (pg/mL)",90-04-0,Race/eth: Non-hispanic white,42.3457167533458,49.9,92.9,233,608,862,2013-2014,0.0214408233276158
"o-Anisidine, urine (pg/mL)",90-04-0,Race/eth: Other,51.0657228703851,38.7,72.2,186,343,357,2013-2014,0.0214408233276158
O-Phenylphenol (ug/L),90-43-7,Gender: female,,,,0.5,1.4,1350,2009-2010,0.770825754819935
O-Phenylphenol (ug/L),90-43-7,Gender: male,,,,0.5,1.4,1399,2009-2010,0.770825754819935
O-Phenylphenol (ug/L),90-43-7,Income: Missing,,,,0.7,1.6,258,2009-2010,0.770825754819935
O-Phenylphenol (ug/L),90-43-7,Income: PIR above 2,,,,0.5,1.1,1371,2009-2010,0.770825754819935
O-Phenylphenol (ug/L),90-43-7,Income: PIR below 2,,,,0.5,1.7,1120,2009-2010,0.770825754819935
O-Phenylphenol (ug/L),90-43-7,Race/eth: Hispanic,,,,0.5,1.3,859,2009-2010,0.770825754819935
O-Phenylphenol (ug/L),90-43-7,Race/eth: Non-hispanic black,,,0.2,0.7,1.2,516,2009-2010,0.770825754819935
O-Phenylphenol (ug/L),90-43-7,Race/eth: Non-hispanic white,,,,0.5,1.7,1206,2009-2010,0.770825754819935
O-Phenylphenol (ug/L),90-43-7,Race/eth: Other,,,,0.3,1.1,168,2009-2010,0.770825754819935
Styrene metabolite: Mandelic acid (ng/mL),100-42-5,Gender: female,109.085971409653,114,206,453,877,1516,2015-2016,0.0123005319148936
Styrene metabolite: Mandelic acid (ng/mL),100-42-5,Gender: male,137.821936434509,148,245,467,923,1492,2015-2016,0.0123005319148936
Styrene metabolite: Mandelic acid (ng/mL),100-42-5,Income: Missing,129.640046758734,128,244,692,1000,310,2015-2016,0.0123005319148936
Styrene metabolite: Mandelic acid (ng/mL),100-42-5,Income: PIR above 2,129.988421946778,136,236,568,1270,1430,2015-2016,0.0123005319148936
Styrene metabolite: Mandelic acid (ng/mL),100-42-5,Income: PIR below 2,117.074872443661,130,217,392,620,1268,2015-2016,0.0123005319148936
Styrene metabolite: Mandelic acid (ng/mL),100-42-5,Race/eth: Hispanic,118.481135805159,136,217,448,722,968,2015-2016,0.0123005319148936
Styrene metabolite: Mandelic acid (ng/mL),100-42-5,Race/eth: Non-hispanic black,164.91782305275,168,281,622,1540,655,2015-2016,0.0123005319148936
Styrene metabolite: Mandelic acid (ng/mL),100-42-5,Race/eth: Non-hispanic white,121.551686934187,127,221,426,877,909,2015-2016,0.0123005319148936
Styrene metabolite: Mandelic acid (ng/mL),100-42-5,Race/eth: Other,104.52332579676,108,206,407,861,476,2015-2016,0.0123005319148936
"2-Aminonaphthalene, urine (pg/mL)",91-59-8,Gender: female,4.49130586859168,4.35,8.2,31.8,83,1245,2013-2014,0.255225080385852
"2-Aminonaphthalene, urine (pg/mL)",91-59-8,Gender: male,5.29090771398398,5.29,9.81,35.7,80.3,1243,2013-2014,0.255225080385852
"2-Aminonaphthalene, urine (pg/mL)",91-59-8,Income: Missing,3.92970438998971,3.73,7.96,28.3,98.9,177,2013-2014,0.255225080385852
"2-Aminonaphthalene, urine (pg/mL)",91-59-8,Income: PIR above 2,5.99823455433146,6.01,11.6,41.3,116,1209,2013-2014,0.255225080385852
"2-Aminonaphthalene, urine (pg/mL)",91-59-8,Income: PIR below 2,4.35325601588181,4.25,8.01,28,76.7,1102,2013-2014,0.255225080385852
"2-Aminonaphthalene, urine (pg/mL)",91-59-8,Race/eth: Hispanic,8.17535316765802,4.15,7.34,18.6,34.8,669,2013-2014,0.255225080385852
"2-Aminonaphthalene, urine (pg/mL)",91-59-8,Race/eth: Non-hispanic black,4.00602505877246,7.9,16,48.3,121,532,2013-2014,0.255225080385852
"2-Aminonaphthalene, urine (pg/mL)",91-59-8,Race/eth: Non-hispanic white,4.08683994010163,4.63,8.75,35.6,86.9,913,2013-2014,0.255225080385852
"2-Aminonaphthalene, urine (pg/mL)",91-59-8,Race/eth: Other,4.7651791171799,3.91,6.87,25,51,374,2013-2014,0.255225080385852
"4-Aminobiphenyl, urine (pg/mL)",92-67-1,Gender: female,5.08586237486752,5.47,10.6,46.6,123,1247,2013-2014,0.218298555377207
"4-Aminobiphenyl, urine (pg/mL)",92-67-1,Gender: male,5.51375425436044,6.11,10.6,42.1,88.3,1245,2013-2014,0.218298555377207
"4-Aminobiphenyl, urine (pg/mL)",92-67-1,Income: Missing,4.72496660477356,5.52,8.44,35.2,88.3,177,2013-2014,0.218298555377207
"4-Aminobiphenyl, urine (pg/mL)",92-67-1,Income: PIR above 2,6.38396529609001,6.59,13.6,55.7,134,1208,2013-2014,0.218298555377207
"4-Aminobiphenyl, urine (pg/mL)",92-67-1,Income: PIR below 2,4.74616415647299,5.4,9.84,37,68.3,1107,2013-2014,0.218298555377207
"4-Aminobiphenyl, urine (pg/mL)",92-67-1,Race/eth: Hispanic,7.6690512810439,5.47,8.75,27.1,45.8,660,2013-2014,0.218298555377207
"4-Aminobiphenyl, urine (pg/mL)",92-67-1,Race/eth: Non-hispanic black,4.43009810540764,7.86,17.2,59.5,101,538,2013-2014,0.218298555377207
"4-Aminobiphenyl, urine (pg/mL)",92-67-1,Race/eth: Non-hispanic white,4.4490943507656,5.76,10.6,48.1,96.8,914,2013-2014,0.218298555377207
"4-Aminobiphenyl, urine (pg/mL)",92-67-1,Race/eth: Other,5.30262701142683,5,8.94,34.5,65.9,380,2013-2014,0.218298555377207
N-Nitrosopyrrolidine (ng/L),930-55-2,Gender: female,,,,,,1293,2013-2014,0.995354239256678
N-Nitrosopyrrolidine (ng/L),930-55-2,Gender: male,,,,,,1290,2013-2014,0.995354239256678
N-Nitrosopyrrolidine (ng/L),930-55-2,Income: Missing,,,,,,181,2013-2014,0.995354239256678
N-Nitrosopyrrolidine (ng/L),930-55-2,Income: PIR above 2,,,,,,1253,2013-2014,0.995354239256678
N-Nitrosopyrrolidine (ng/L),930-55-2,Income: PIR below 2,,,,,,1149,2013-2014,0.995354239256678
N-Nitrosopyrrolidine (ng/L),930-55-2,Race/eth: Hispanic,,,,,,688,2013-2014,0.995354239256678
N-Nitrosopyrrolidine (ng/L),930-55-2,Race/eth: Non-hispanic black,,,,,,558,2013-2014,0.995354239256678
N-Nitrosopyrrolidine (ng/L),930-55-2,Race/eth: Non-hispanic white,,,,,,948,2013-2014,0.995354239256678
N-Nitrosopyrrolidine (ng/L),930-55-2,Race/eth: Other,,,,,,389,2013-2014,0.995354239256678
"2,4-D (ug/L)",94-75-7,Gender: female,0.251215902087917,0.257,0.462,1.26,2.79,1326,2013-2014,0.246724073380756
"2,4-D (ug/L)",94-75-7,Gender: male,0.31958970706832,0.332,0.577,1.56,4.84,1345,2013-2014,0.246724073380756
"2,4-D (ug/L)",94-75-7,Income: Missing,0.278159986445864,0.26,0.501,1.66,3.64,191,2013-2014,0.246724073380756
"2,4-D (ug/L)",94-75-7,Income: PIR above 2,0.28902686093757,0.3,0.521,1.44,2.94,1199,2013-2014,0.246724073380756
"2,4-D (ug/L)",94-75-7,Income: PIR below 2,0.2736389733928,0.273,0.495,1.41,5.82,1281,2013-2014,0.246724073380756
"2,4-D (ug/L)",94-75-7,Race/eth: Hispanic,0.283452119312353,0.25,0.424,1.32,4.84,671,2013-2014,0.246724073380756
"2,4-D (ug/L)",94-75-7,Race/eth: Non-hispanic black,0.25142683532255,0.294,0.539,1.2,2.58,590,2013-2014,0.246724073380756
"2,4-D (ug/L)",94-75-7,Race/eth: Non-hispanic white,0.295436510338529,0.307,0.526,1.5,4.13,1017,2013-2014,0.246724073380756
"2,4-D (ug/L)",94-75-7,Race/eth: Other,0.254740779597731,0.268,0.491,1.3,2.79,393,2013-2014,0.246724073380756
"o-Toluidine, urine (pg/mL)",95-53-4,Gender: female,279.299663876014,296,570,1650,4170,1219,2013-2014,0.145936981757877
"o-Toluidine, urine (pg/mL)",95-53-4,Gender: male,330.050844488862,346,649,1840,4760,1193,2013-2014,0.145936981757877
"o-Toluidine, urine (pg/mL)",95-53-4,Income: Missing,278.012821870417,282,608,2180,4950,170,2013-2014,0.145936981757877
"o-Toluidine, urine (pg/mL)",95-53-4,Income: PIR above 2,340.347624031095,374,667,1920,4330,1173,2013-2014,0.145936981757877
"o-Toluidine, urine (pg/mL)",95-53-4,Income: PIR below 2,283.843047244801,296,568,1410,4170,1069,2013-2014,0.145936981757877
"o-Toluidine, urine (pg/mL)",95-53-4,Race/eth: Hispanic,464.475916654066,315,566,1560,4390,651,2013-2014,0.145936981757877
"o-Toluidine, urine (pg/mL)",95-53-4,Race/eth: Non-hispanic black,258.040815882421,489,873,2130,4700,516,2013-2014,0.145936981757877
"o-Toluidine, urine (pg/mL)",95-53-4,Race/eth: Non-hispanic white,296.990695324678,299,580,1670,4290,884,2013-2014,0.145936981757877
"o-Toluidine, urine (pg/mL)",95-53-4,Race/eth: Other,287.817687526888,273,547,1650,4370,361,2013-2014,0.145936981757877
"Blood 1,2-Dibromo-3-chloropropane (ng/mL)",96-12-8,Gender: female,,,,,,1718,2009-2010,1
"Blood 1,2-Dibromo-3-chloropropane (ng/mL)",96-12-8,Gender: male,,,,,,1673,2009-2010,1
"Blood 1,2-Dibromo-3-chloropropane (ng/mL)",96-12-8,Income: Missing,,,,,,301,2009-2010,1
"Blood 1,2-Dibromo-3-chloropropane (ng/mL)",96-12-8,Income: PIR above 2,,,,,,1469,2009-2010,1
"Blood 1,2-Dibromo-3-chloropropane (ng/mL)",96-12-8,Income: PIR below 2,,,,,,1621,2009-2010,1
"Blood 1,2-Dibromo-3-chloropropane (ng/mL)",96-12-8,Race/eth: Hispanic,,,,,,1042,2009-2010,1
"Blood 1,2-Dibromo-3-chloropropane (ng/mL)",96-12-8,Race/eth: Non-hispanic black,,,,,,602,2009-2010,1
"Blood 1,2-Dibromo-3-chloropropane (ng/mL)",96-12-8,Race/eth: Non-hispanic white,,,,,,1536,2009-2010,1
"Blood 1,2-Dibromo-3-chloropropane (ng/mL)",96-12-8,Race/eth: Other,,,,,,211,2009-2010,1
"Blood 1,2,3-trichloropropane (ng/ml)",96-18-4,Gender: female,,,,,,1473,2017-2018,1
"Blood 1,2,3-trichloropropane (ng/ml)",96-18-4,Gender: male,,,,,,1393,2017-2018,1
"Blood 1,2,3-trichloropropane (ng/ml)",96-18-4,Income: Missing,,,,,,1197,2017-2018,1
"Blood 1,2,3-trichloropropane (ng/ml)",96-18-4,Income: PIR above 2,,,,,,378,2017-2018,1
"Blood 1,2,3-trichloropropane (ng/ml)",96-18-4,Income: PIR below 2,,,,,,1291,2017-2018,1
"Blood 1,2,3-trichloropropane (ng/ml)",96-18-4,Race/eth: Hispanic,,,,,,682,2017-2018,1
"Blood 1,2,3-trichloropropane (ng/ml)",96-18-4,Race/eth: Non-hispanic black,,,,,,637,2017-2018,1
"Blood 1,2,3-trichloropropane (ng/ml)",96-18-4,Race/eth: Non-hispanic white,,,,,,977,2017-2018,1
"Blood 1,2,3-trichloropropane (ng/ml)",96-18-4,Race/eth: Other,,,,,,570,2017-2018,1
Ethylenethio urea (ug/L),96-45-7,Gender: female,,,,0.41,1.67,1282,2007-2008,0.925320886814469
Ethylenethio urea (ug/L),96-45-7,Gender: male,,,,0.43,1.2,1289,2007-2008,0.925320886814469
Ethylenethio urea (ug/L),96-45-7,Income: Missing,,,,0.44,5.07,248,2007-2008,0.925320886814469
Ethylenethio urea (ug/L),96-45-7,Income: PIR above 2,,,,0.34,1.28,1104,2007-2008,0.925320886814469
Ethylenethio urea (ug/L),96-45-7,Income: PIR below 2,,,,0.6,1.56,1219,2007-2008,0.925320886814469
Ethylenethio urea (ug/L),96-45-7,Race/eth: Hispanic,,,,0.49,2.14,790,2007-2008,0.925320886814469
Ethylenethio urea (ug/L),96-45-7,Race/eth: Non-hispanic black,,,,0.63,5.07,570,2007-2008,0.925320886814469
Ethylenethio urea (ug/L),96-45-7,Race/eth: Non-hispanic white,,,,0.3,1.12,1084,2007-2008,0.925320886814469
Ethylenethio urea (ug/L),96-45-7,Race/eth: Other,,,,1.19,1.88,127,2007-2008,0.925320886814469
Blood isopropylbenzene (ng/mL),98-82-8,Gender: female,,,,,,1443,2017-2018,0.997142857142857
Blood isopropylbenzene (ng/mL),98-82-8,Gender: male,,,,,,1357,2017-2018,0.997142857142857
Blood isopropylbenzene (ng/mL),98-82-8,Income: Missing,,,,,,1180,2017-2018,0.997142857142857
Blood isopropylbenzene (ng/mL),98-82-8,Income: PIR above 2,,,,,,370,2017-2018,0.997142857142857
Blood isopropylbenzene (ng/mL),98-82-8,Income: PIR below 2,,,,,,1250,2017-2018,0.997142857142857
Blood isopropylbenzene (ng/mL),98-82-8,Race/eth: Hispanic,,,,,,681,2017-2018,0.997142857142857
Blood isopropylbenzene (ng/mL),98-82-8,Race/eth: Non-hispanic black,,,,,,617,2017-2018,0.997142857142857
Blood isopropylbenzene (ng/mL),98-82-8,Race/eth: Non-hispanic white,,,,,,955,2017-2018,0.997142857142857
Blood isopropylbenzene (ng/mL),98-82-8,Race/eth: Other,,,,,,547,2017-2018,0.997142857142857
Blood Nitrobenzene (ng/mL),98-95-3,Gender: female,,,,,,1466,2017-2018,1
Blood Nitrobenzene (ng/mL),98-95-3,Gender: male,,,,,,1380,2017-2018,1
Blood Nitrobenzene (ng/mL),98-95-3,Income: Missing,,,,,,1189,2017-2018,1
Blood Nitrobenzene (ng/mL),98-95-3,Income: PIR above 2,,,,,,376,2017-2018,1
Blood Nitrobenzene (ng/mL),98-95-3,Income: PIR below 2,,,,,,1281,2017-2018,1
Blood Nitrobenzene (ng/mL),98-95-3,Race/eth: Hispanic,,,,,,678,2017-2018,1
Blood Nitrobenzene (ng/mL),98-95-3,Race/eth: Non-hispanic black,,,,,,630,2017-2018,1
Blood Nitrobenzene (ng/mL),98-95-3,Race/eth: Non-hispanic white,,,,,,971,2017-2018,1
Blood Nitrobenzene (ng/mL),98-95-3,Race/eth: Other,,,,,,567,2017-2018,1
